
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research Autopsy - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="ABCBAB9B926534833DAB9B000C97C034.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="jtocrr">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8474405/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="JTO Clinical and Research Reports">
<meta name="citation_title" content="Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research Autopsy">
<meta name="citation_author" content="Hui-Zi Chen">
<meta name="citation_author_institution" content="Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin">
<meta name="citation_author_institution" content="Genomic Sciences and Precision Medicine Center and Cancer Center, Medical College of Wisconsin, Milwaukee, Wisconsin">
<meta name="citation_author" content="Russell Bonneville">
<meta name="citation_author_institution" content="Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio">
<meta name="citation_author_institution" content="Biomedical Sciences Graduate Program, The Ohio State University, Columbus, Ohio">
<meta name="citation_author" content="Anoosha Paruchuri">
<meta name="citation_author_institution" content="Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio">
<meta name="citation_author" content="Julie W Reeser">
<meta name="citation_author_institution" content="Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio">
<meta name="citation_author" content="Michele R Wing">
<meta name="citation_author_institution" content="Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio">
<meta name="citation_author" content="Eric Samorodnitsky">
<meta name="citation_author_institution" content="Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio">
<meta name="citation_author" content="Melanie A Krook">
<meta name="citation_author_institution" content="Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio">
<meta name="citation_author" content="Amy M Smith">
<meta name="citation_author_institution" content="Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio">
<meta name="citation_author" content="Thuy Dao">
<meta name="citation_author_institution" content="Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio">
<meta name="citation_author" content="Jharna Miya">
<meta name="citation_author_institution" content="Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio">
<meta name="citation_author" content="Walter Wang">
<meta name="citation_author_institution" content="Medical Scientist Training Program, The Ohio State University, Columbus, Ohio">
<meta name="citation_author" content="Lianbo Yu">
<meta name="citation_author_institution" content="Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio">
<meta name="citation_author" content="Aharon G Freud">
<meta name="citation_author_institution" content="Division of Hematopathology, Department of Pathology, The Ohio State University, Columbus, Ohio">
<meta name="citation_author" content="Patricia Allenby">
<meta name="citation_author_institution" content="Division of Autopsy Services, Department of Pathology, The Ohio State University, Columbus, Ohio">
<meta name="citation_author" content="Sharon Cole">
<meta name="citation_author_institution" content="Orion Cancer Care, Inc., Blanchard Valley Health System, Findlay, Ohio">
<meta name="citation_author" content="Gregory Otterson">
<meta name="citation_author_institution" content="Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio">
<meta name="citation_author_institution" content="James Thoracic Center, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio">
<meta name="citation_author" content="Peter Shields">
<meta name="citation_author_institution" content="Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio">
<meta name="citation_author_institution" content="James Thoracic Center, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio">
<meta name="citation_author" content="David P Carbone">
<meta name="citation_author_institution" content="Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio">
<meta name="citation_author_institution" content="James Thoracic Center, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio">
<meta name="citation_author" content="Sameek Roychowdhury">
<meta name="citation_author_institution" content="Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio">
<meta name="citation_author_institution" content="The James Cancer Hospital, The Ohio State University, Columbus, Ohio">
<meta name="citation_publication_date" content="2021 Mar 11">
<meta name="citation_volume" content="2">
<meta name="citation_issue" content="4">
<meta name="citation_firstpage" content="100164">
<meta name="citation_doi" content="10.1016/j.jtocrr.2021.100164">
<meta name="citation_pmid" content="34590014">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8474405/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8474405/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8474405/pdf/main.pdf">
<meta name="description" content="Relapsed SCLC is characterized by therapeutic resistance and high mortality rate. Despite decades of research, mechanisms responsible for therapeutic resistance have remained elusive owing to limited tissues available for molecular studies. Thus, ...">
<meta name="og:title" content="Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research Autopsy">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Relapsed SCLC is characterized by therapeutic resistance and high mortality rate. Despite decades of research, mechanisms responsible for therapeutic resistance have remained elusive owing to limited tissues available for molecular studies. Thus, ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8474405/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="8474405">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1016/j.jtocrr.2021.100164"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/main.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC8474405%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/8474405/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/8474405/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC8474405/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-jtocrr.gif" alt="JTO Clinical and Research Reports logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to JTO Clinical and Research Reports" title="Link to JTO Clinical and Research Reports" shape="default" href="https://www.journals.elsevier.com/jto-clinical-and-research-reports" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">JTO Clin Res Rep</button></div>. 2021 Mar 11;2(4):100164. doi: <a href="https://doi.org/10.1016/j.jtocrr.2021.100164" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1016/j.jtocrr.2021.100164</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22JTO%20Clin%20Res%20Rep%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22JTO%20Clin%20Res%20Rep%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22JTO%20Clin%20Res%20Rep%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22JTO%20Clin%20Res%20Rep%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research Autopsy</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20HZ%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Hui-Zi Chen</span></a><div hidden="hidden" id="id1">
<h3>
<span class="name western">Hui-Zi Chen</span>, <span class="degrees">MD, PhD</span>
</h3>
<div class="p">
<sup>a</sup>Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin</div>
<div class="p">
<sup>b</sup>Genomic Sciences and Precision Medicine Center and Cancer Center, Medical College of Wisconsin, Milwaukee, Wisconsin</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20HZ%22%5BAuthor%5D" class="usa-link"><span class="name western">Hui-Zi Chen</span></a>
</div>
</div>
<sup>a,</sup><sup>b</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bonneville%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Russell Bonneville</span></a><div hidden="hidden" id="id2">
<h3>
<span class="name western">Russell Bonneville</span>, <span class="degrees">BS</span>
</h3>
<div class="p">
<sup>c</sup>Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio</div>
<div class="p">
<sup>d</sup>Biomedical Sciences Graduate Program, The Ohio State University, Columbus, Ohio</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bonneville%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Russell Bonneville</span></a>
</div>
</div>
<sup>c,</sup><sup>d</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Paruchuri%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Anoosha Paruchuri</span></a><div hidden="hidden" id="id3">
<h3>
<span class="name western">Anoosha Paruchuri</span>, <span class="degrees">PhD</span>
</h3>
<div class="p">
<sup>c</sup>Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Paruchuri%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Anoosha Paruchuri</span></a>
</div>
</div>
<sup>c</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Reeser%20JW%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Julie W Reeser</span></a><div hidden="hidden" id="id4">
<h3>
<span class="name western">Julie W Reeser</span>, <span class="degrees">PhD</span>
</h3>
<div class="p">
<sup>c</sup>Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Reeser%20JW%22%5BAuthor%5D" class="usa-link"><span class="name western">Julie W Reeser</span></a>
</div>
</div>
<sup>c</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wing%20MR%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Michele R Wing</span></a><div hidden="hidden" id="id5">
<h3>
<span class="name western">Michele R Wing</span>, <span class="degrees">PhD</span>
</h3>
<div class="p">
<sup>c</sup>Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wing%20MR%22%5BAuthor%5D" class="usa-link"><span class="name western">Michele R Wing</span></a>
</div>
</div>
<sup>c</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Samorodnitsky%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Eric Samorodnitsky</span></a><div hidden="hidden" id="id6">
<h3>
<span class="name western">Eric Samorodnitsky</span>, <span class="degrees">PhD</span>
</h3>
<div class="p">
<sup>c</sup>Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Samorodnitsky%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Eric Samorodnitsky</span></a>
</div>
</div>
<sup>c</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Krook%20MA%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Melanie A Krook</span></a><div hidden="hidden" id="id7">
<h3>
<span class="name western">Melanie A Krook</span>, <span class="degrees">PhD</span>
</h3>
<div class="p">
<sup>c</sup>Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Krook%20MA%22%5BAuthor%5D" class="usa-link"><span class="name western">Melanie A Krook</span></a>
</div>
</div>
<sup>c</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Smith%20AM%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Amy M Smith</span></a><div hidden="hidden" id="id8">
<h3>
<span class="name western">Amy M Smith</span>, <span class="degrees">BS</span>
</h3>
<div class="p">
<sup>c</sup>Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Smith%20AM%22%5BAuthor%5D" class="usa-link"><span class="name western">Amy M Smith</span></a>
</div>
</div>
<sup>c</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dao%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Thuy Dao</span></a><div hidden="hidden" id="id9">
<h3>
<span class="name western">Thuy Dao</span>, <span class="degrees">BS</span>
</h3>
<div class="p">
<sup>c</sup>Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dao%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Thuy Dao</span></a>
</div>
</div>
<sup>c</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Miya%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Jharna Miya</span></a><div hidden="hidden" id="id10">
<h3>
<span class="name western">Jharna Miya</span>, <span class="degrees">MS</span>
</h3>
<div class="p">
<sup>c</sup>Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Miya%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jharna Miya</span></a>
</div>
</div>
<sup>c</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Walter Wang</span></a><div hidden="hidden" id="id11">
<h3>
<span class="name western">Walter Wang</span>, <span class="degrees">BS</span>
</h3>
<div class="p">
<sup>e</sup>Medical Scientist Training Program, The Ohio State University, Columbus, Ohio</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Walter Wang</span></a>
</div>
</div>
<sup>e</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yu%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Lianbo Yu</span></a><div hidden="hidden" id="id12">
<h3>
<span class="name western">Lianbo Yu</span>, <span class="degrees">PhD</span>
</h3>
<div class="p">
<sup>f</sup>Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yu%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lianbo Yu</span></a>
</div>
</div>
<sup>f</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Freud%20AG%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Aharon G Freud</span></a><div hidden="hidden" id="id13">
<h3>
<span class="name western">Aharon G Freud</span>, <span class="degrees">MD, PhD</span>
</h3>
<div class="p">
<sup>g</sup>Division of Hematopathology, Department of Pathology, The Ohio State University, Columbus, Ohio</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Freud%20AG%22%5BAuthor%5D" class="usa-link"><span class="name western">Aharon G Freud</span></a>
</div>
</div>
<sup>g</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Allenby%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Patricia Allenby</span></a><div hidden="hidden" id="id14">
<h3>
<span class="name western">Patricia Allenby</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>h</sup>Division of Autopsy Services, Department of Pathology, The Ohio State University, Columbus, Ohio</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Allenby%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Patricia Allenby</span></a>
</div>
</div>
<sup>h</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cole%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Sharon Cole</span></a><div hidden="hidden" id="id15">
<h3>
<span class="name western">Sharon Cole</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>i</sup>Orion Cancer Care, Inc., Blanchard Valley Health System, Findlay, Ohio</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cole%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sharon Cole</span></a>
</div>
</div>
<sup>i</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Otterson%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Gregory Otterson</span></a><div hidden="hidden" id="id16">
<h3>
<span class="name western">Gregory Otterson</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>c</sup>Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio</div>
<div class="p">
<sup>j</sup>James Thoracic Center, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Otterson%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Gregory Otterson</span></a>
</div>
</div>
<sup>c,</sup><sup>j</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shields%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Peter Shields</span></a><div hidden="hidden" id="id17">
<h3>
<span class="name western">Peter Shields</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>c</sup>Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio</div>
<div class="p">
<sup>j</sup>James Thoracic Center, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shields%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Peter Shields</span></a>
</div>
</div>
<sup>c,</sup><sup>j</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Carbone%20DP%22%5BAuthor%5D" class="usa-link" aria-describedby="id18"><span class="name western">David P Carbone</span></a><div hidden="hidden" id="id18">
<h3>
<span class="name western">David P Carbone</span>, <span class="degrees">MD, PhD</span>
</h3>
<div class="p">
<sup>c</sup>Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio</div>
<div class="p">
<sup>j</sup>James Thoracic Center, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Carbone%20DP%22%5BAuthor%5D" class="usa-link"><span class="name western">David P Carbone</span></a>
</div>
</div>
<sup>c,</sup><sup>j</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Roychowdhury%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id19"><span class="name western">Sameek Roychowdhury</span></a><div hidden="hidden" id="id19">
<h3>
<span class="name western">Sameek Roychowdhury</span>, <span class="degrees">MD, PhD</span>
</h3>
<div class="p">
<sup>c</sup>Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio</div>
<div class="p">
<sup>k</sup>The James Cancer Hospital, The Ohio State University, Columbus, Ohio</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Roychowdhury%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sameek Roychowdhury</span></a>
</div>
</div>
<sup>c,</sup><sup>k,</sup><sup>∗</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>a</sup>Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin</div>
<div id="aff2">
<sup>b</sup>Genomic Sciences and Precision Medicine Center and Cancer Center, Medical College of Wisconsin, Milwaukee, Wisconsin</div>
<div id="aff3">
<sup>c</sup>Division of Medical Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio</div>
<div id="aff4">
<sup>d</sup>Biomedical Sciences Graduate Program, The Ohio State University, Columbus, Ohio</div>
<div id="aff5">
<sup>e</sup>Medical Scientist Training Program, The Ohio State University, Columbus, Ohio</div>
<div id="aff6">
<sup>f</sup>Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio</div>
<div id="aff7">
<sup>g</sup>Division of Hematopathology, Department of Pathology, The Ohio State University, Columbus, Ohio</div>
<div id="aff8">
<sup>h</sup>Division of Autopsy Services, Department of Pathology, The Ohio State University, Columbus, Ohio</div>
<div id="aff9">
<sup>i</sup>Orion Cancer Care, Inc., Blanchard Valley Health System, Findlay, Ohio</div>
<div id="aff10">
<sup>j</sup>James Thoracic Center, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio</div>
<div id="aff11">
<sup>k</sup>The James Cancer Hospital, The Ohio State University, Columbus, Ohio</div>
<div class="author-notes p"><div class="fn" id="cor1">
<sup>∗</sup><p class="display-inline">Corresponding author. Address for correspondence: Sameek Roychowdhury, MD, PhD, Division of Medical Oncology, Department of Internal Medicine; Comprehensive Cancer Center; and The James Cancer Hospital, The Ohio State University, 460 West 12th Avenue, Biomedical Research Tower, Room 508, Columbus, OH 43210. <span>Sameek.Roychowdhury@osumc.edu</span></p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2021 Feb 28; Accepted 2021 Mar 5; Collection date 2021 Apr.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2021 The Authors</div>
<p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC8474405  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34590014/" class="usa-link">34590014</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abs0010"><h2>Abstract</h2>
<section id="sec1_pmc"><h3 class="pmc_sec_title">Introduction</h3>
<p>Relapsed SCLC is characterized by therapeutic resistance and high mortality rate. Despite decades of research, mechanisms responsible for therapeutic resistance have remained elusive owing to limited tissues available for molecular studies. Thus, an unmet need remains for molecular characterization of relapsed SCLC to facilitate development of effective therapies.</p></section><section id="sec2_pmc"><h3 class="pmc_sec_title">Methods</h3>
<p>We performed whole-exome and transcriptome sequencing of metastatic tumor samples procured from research autopsies of five patients with relapsed SCLC. We implemented bioinformatics tools to infer subclonal phylogeny and identify recurrent genomic alterations. We implemented immune cell signature and single-sample gene set enrichment analyses on tumor and normal transcriptome data from autopsy and additional primary and relapsed SCLC data sets. Furthermore, we evaluated T cell-inflamed gene expression profiles in neuroendocrine (<em>ASCL1</em>, <em>NEUROD1</em>) and non-neuroendocrine (<em>YAP1</em>, <em>POU2F3</em>) SCLC subtypes.</p></section><section id="sec3_pmc"><h3 class="pmc_sec_title">Results</h3>
<p>Exome sequencing revealed clonal heterogeneity (intertumor and intratumor) arising from branched evolution and identified resistance-associated truncal and subclonal alterations in relapsed SCLC. Transcriptome analyses further revealed a noninflamed phenotype in neuroendocrine SCLC subtypes (<em>ASCL1</em>, <em>NEUROD1</em>) associated with decreased expression of genes involved in adaptive antitumor immunity whereas non-neuroendocrine subtypes (<em>YAP1</em>, <em>POU2F3</em>) revealed a more inflamed phenotype.</p></section><section id="sec4_pmc"><h3 class="pmc_sec_title">Conclusions</h3>
<p>Our results reveal substantial tumor heterogeneity and complex clonal evolution in relapsed SCLC. Furthermore, we report that neuroendocrine SCLC subtypes are immunologically cold, thus explaining decreased responsiveness to immune checkpoint blockade. These results suggest that the mechanisms of innate and acquired therapeutic resistances are subtype-specific in SCLC and highlight the need for continued investigation to bolster therapy selection and development for this cancer.</p></section><section id="kwrds0010" class="kwd-group"><p><strong>Keywords:</strong> Small cell lung cancer, Research autopsy, Tumor heterogeneity, Treatment resistance</p></section></section><section id="sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="p0010">SCLC is a lethal neuroendocrine malignancy accounting for 13% to 15% of new lung cancer cases annually worldwide.<a href="#bib1" class="usa-link" aria-describedby="bib1"><sup>1</sup></a><sup>,</sup><a href="#bib2" class="usa-link" aria-describedby="bib2"><sup>2</sup></a> Most patients with SCLC present with initially chemotherapy-sensitive disease, but almost all will experience progression or relapse leading to death. In 2019, combination chemotherapy and immunotherapy was approved by the Food and Drug Administration as first-line treatment for metastatic SCLC,<a href="#bib3" class="usa-link" aria-describedby="bib3"><sup>3</sup></a><sup>,</sup><a href="#bib4" class="usa-link" aria-describedby="bib4"><sup>4</sup></a> with modest 2-month improvement in survival compared with chemotherapy alone. For decades, topotecan was the only Food and Drug Administration–approved second-line chemotherapy with objective response rate of 10% to 20%,<a href="#bib5" class="usa-link" aria-describedby="bib5"><sup>5</sup></a> until lurbinectedin was granted accelerated approval in 2020 on the basis of a phase 2 trial revealing 35% objective response rate.<a href="#bib6" class="usa-link" aria-describedby="bib6"><sup>6</sup></a> Despite these recent approvals, there is an urgent need to develop more effective therapies for advanced SCLC.</p>
<p id="p0015">Key studies in the past decade have profiled the mutational landscape of primary SCLC, driven by <em>TP53</em> and <em>RB1</em> inactivation.<a href="#bib7" class="usa-link" aria-describedby="bib7">7</a>, <a href="#bib8" class="usa-link" aria-describedby="bib8">8</a>, <a href="#bib9" class="usa-link" aria-describedby="bib9">9</a> Furthermore, distinct SCLC subgroups have been identified on the basis of the expression of key transcription factors including ASCL1 and NEUROD1.<a href="#bib10" class="usa-link" aria-describedby="bib10"><sup>10</sup></a><sup>,</sup><a href="#bib11" class="usa-link" aria-describedby="bib11"><sup>11</sup></a> How each SCLC subtype confers different clinical phenotypes and differential response to anticancer therapies is under active investigation,<a href="#bib12" class="usa-link" aria-describedby="bib12"><sup>12</sup></a> with the goal of delivering precision therapy to patients with SCLC by matching each SCLC subtype to specific treatments.</p>
<p id="p0020">Molecular characterization of relapsed SCLC has been hampered by tissue scarcity owing to rapid clinical deterioration of patients with relapse. Therefore, unlike for primary SCLC, less is known on the genomic and transcriptomic landscapes of relapsed SCLC and mechanisms that mediate therapeutic resistance, although recent nonautopsy studies on relapsed SCLC have begun to address this knowledge gap. For example, Gardner et al.<a href="#bib13" class="usa-link" aria-describedby="bib13"><sup>13</sup></a> used patient-derived xenografts of paired chemosensitive and chemoresistant SCLC tumors to elegantly reveal that acquired chemoresistance occurred through epigenetic silencing of a DNA damage repair factor, <em>SLFN11</em>. Wagner et al<em>.</em><a href="#bib14" class="usa-link" aria-describedby="bib14"><sup>14</sup></a> performed genomic profiling on a cohort of patients with relapsed SCLC and identified recurrent Wnt pathway alterations as a mechanism of acquired chemoresistance. Weiss et al<em>.</em><a href="#bib15" class="usa-link" aria-describedby="bib15"><sup>15</sup></a> performed genome-wide exome and RNA sequencing (RNA-seq) on 12 patients with SCLC who relapsed after platinum-based chemotherapy. Aside from driver mutations in <em>RB1</em> and <em>TP53</em>, the authors identified few recurrent targetable genomic alterations in this cohort of patients. Finally, an important study by Stewart et al.<a href="#bib16" class="usa-link" aria-describedby="bib16"><sup>16</sup></a> performed single-cell sequencing of circulating tumor cells and circulating tumor cell-derived xenografts from patients with platinum-sensitive and refractory SCLC and revealed an association between increased intratumoral heterogeneity and chemoresistance. The latter study is one of the first nonautopsy studies to directly evaluate intratumor heterogeneity in advanced SCLC. Overall, however, further study of relapsed SCLC is needed to identify additional targetable mechanisms underlying therapeutic resistance, including resistance to immunotherapy, which is now approved for frontline treatment in the metastatic setting.</p>
<p id="p0025">The use of tumor specimens from rapid research autopsy has accelerated the study of tumor heterogeneity and acquired resistance in advanced cancer.<a href="#bib17" class="usa-link" aria-describedby="bib17"><sup>17</sup></a> To our knowledge, this is the first study to perform whole-exome and transcriptome profiling of advanced SCLC through research autopsy. From exome sequencing, we inferred intertumor and intratumor clonal heterogeneity arising from branched evolution and transcriptome analyses supported the subtype-specific suppression of adaptive antitumor immunity in primary and advanced SCLC. Our results provide new insights into the subclonal architecture of advanced SCLC and identify new potentially targetable pathways involved in antitumor immune responses.</p></section><section id="sec2"><h2 class="pmc_sec_title">Materials and Methods</h2>
<section id="sec2.1"><h3 class="pmc_sec_title">Rapid Research Autopsy</h3>
<p id="p0030">Informed consents were obtained from five patients with advanced SCLC to participate in an institutional review board–approved clinical study for tumor profiling by next-generation sequencing and body donation (<a href="https://clinicaltrials.gov/ct2/show/NCT02090530" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT02090530</a>).<a href="#bib17" class="usa-link" aria-describedby="bib17"><sup>17</sup></a><sup>,</sup><a href="#bib18" class="usa-link" aria-describedby="bib18"><sup>18</sup></a> Deceased patients were transported to The Ohio State University Regional Autopsy Center, where research autopsy for tumor procurement was performed no more than 16 hours after the passing of the patients. Computed tomography imaging when available was used to guide procurement from organs with cancer. After autopsy completion, the deceased were transported to a designated funeral home within 24 hours.</p></section><section id="sec2.2"><h3 class="pmc_sec_title">Tumor DNA/RNA-Seq</h3>
<p id="p0035">Samples with tumor cell content greater than 60% and without substantial necrosis were selected for next-generation sequencing analyses. Genomic DNA and total RNA were extracted using Qiagen kits per manufacturer’s protocol. Libraries were prepared after established protocols (TruSeq Stranded Total RNA with RiboZero Gold, Illumina),<a href="#bib18" class="usa-link" aria-describedby="bib18"><sup>18</sup></a><sup>,</sup><a href="#bib19" class="usa-link" aria-describedby="bib19"><sup>19</sup></a> enriched with the xGEN Exome Research Panel version 1.0 (IDT) and sequenced on an Illumina HiSeq 4000.</p></section><section id="sec2.3"><h3 class="pmc_sec_title">Circulating Tumor Sequencing</h3>
<p id="p0040">Circulating tumor DNA (ctDNA) sequencing was isolated using QIAamp Circulating Nucleic Acid Kit (Qiagen) per manufacturer’s protocol. An input of 300 ng was used to generate libraries for paired-end sequencing on a NextSeq instrument achieving median coverage of approximately ×500.<a href="#bib20" class="usa-link" aria-describedby="bib20"><sup>20</sup></a></p></section><section id="sec2.4"><h3 class="pmc_sec_title">Somatic Mutation and Copy Number Variant Calling, Clonal Inference, and Mutational Signatures</h3>
<p id="p0045">These bioinformatics analyses were performed as previously described.<a href="#bib18" class="usa-link" aria-describedby="bib18"><sup>18</sup></a> Briefly, sequencing reads were aligned to human genome build 19 (hg19) using Burrows-Wheeler Aligner (bwa),<a href="#bib21" class="usa-link" aria-describedby="bib21"><sup>21</sup></a> deduplication with Picard (<a href="https://github.com/broadinstitute/picard" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/broadinstitute/picard</a>), and base quality score recombination and realignment around insertion and deletion (indels) with GATK.<a href="#bib22" class="usa-link" aria-describedby="bib22"><sup>22</sup></a> Variants were called with VarScan2<a href="#bib23" class="usa-link" aria-describedby="bib23"><sup>23</sup></a> and allele-specific copy number variations (CNVs) with FALCON.<a href="#bib24" class="usa-link" aria-describedby="bib24"><sup>24</sup></a> Clonal inference was performed using Canopy,<a href="#bib25" class="usa-link" aria-describedby="bib25"><sup>25</sup></a> and mutational signatures were inferred with deconstructSigs.<a href="#bib26" class="usa-link" aria-describedby="bib26"><sup>26</sup></a> Bradley-Terry modeling was used to estimate relative ordering of mutations in the phylogeny branches of autopsy patients with SCLC as previously described.<a href="#bib18" class="usa-link" aria-describedby="bib18"><sup>18</sup></a></p></section><section id="sec2.5"><h3 class="pmc_sec_title">Significantly Mutated Gene Analysis</h3>
<p id="p0050">Significantly mutated gene (SMG) analysis was identified using MuSiC version 2.0,<sup>27</sup> with default settings. Variants from all tumor samples were merged per patient by taking the highest variant allele fraction. The <em>p</em> value and false discovery rate (FDR) estimates are on the basis of three tests including Fisher's combined <em>p</em> value test, convolution test, and likelihood ratio test methods. For a specific gene, if FDR for at least two of these tests is less than or equal to maximum FDR, then it was called as a SMG. For all five SCLC research autopsy patients, the maximum FDR cutoff was set to 0.05.</p></section><section id="sec2.6"><h3 class="pmc_sec_title">Driver Mutation Prediction</h3>
<p id="p0055">CHASM was used to identify statistically likely driver mutations.<a href="#bib28" class="usa-link" aria-describedby="bib28"><sup>28</sup></a> Missense variants were merged per patient and deduplicated before input to CHASM.</p></section><section id="sec2.7"><h3 class="pmc_sec_title">Transcriptome Analysis</h3>
<p id="p0060">RNA-seq reads were aligned to hg19 using HISAT2,<a href="#bib29" class="usa-link" aria-describedby="bib29"><sup>29</sup></a> and fragments per kilobase per million reads and transcript reads per million (TPM) were calculated with StringTie<a href="#bib30" class="usa-link" aria-describedby="bib30"><sup>30</sup></a> as described in the Supplementary Methods.</p></section><section id="sec2.8"><h3 class="pmc_sec_title">Single-Sample Gene Set Enrichment and Immune Signatures</h3>
<p id="p0065">Single-sample gene set enrichment (ssGSEA) version 2.0 was implemented with default settings in R.<a href="#bib31" class="usa-link" aria-describedby="bib31"><sup>31</sup></a> Gene sets assayed were obtained from PanCancer Immuno-Oncology 360 and Tumor Signaling 360 from NanoString. Immune signatures (ImSigs) were run using TPM values with default settings to identify enrichment of 10 ImSig.<a href="#bib32" class="usa-link" aria-describedby="bib32"><sup>32</sup></a> Linear mixed-effects models and <em>t</em> statistics were used to model ssGSEA and ImSig scores by allowing correlation among multiple samples within each patient. Tukey’s method was used for adjusting <em>p</em> values of multiple comparisons of enrichment scores from ssGSEA using NanoString gene sets and scores from ImSig.</p></section><section id="sec2.9"><h3 class="pmc_sec_title">External SCLC RNA-Seq Data Sets</h3>
<p id="p0070">RNA-seq data of primary and relapsed SCLC and normal lung tissue were obtained from four previous publications.<a href="#bib8" class="usa-link" aria-describedby="bib8"><sup>8</sup></a><sup>,</sup><a href="#bib14" class="usa-link" aria-describedby="bib14"><sup>14</sup></a><sup>,</sup><a href="#bib15" class="usa-link" aria-describedby="bib15"><sup>15</sup></a><sup>,</sup><a href="#bib33" class="usa-link" aria-describedby="bib33"><sup>33</sup></a> Of these four data sets, one had paired primary SCLC and normal lung samples,<a href="#bib8" class="usa-link" aria-describedby="bib8"><sup>8</sup></a> whereas the rest contained either exclusively tumor<a href="#bib14" class="usa-link" aria-describedby="bib14"><sup>14</sup></a><sup>,</sup><a href="#bib15" class="usa-link" aria-describedby="bib15"><sup>15</sup></a> or normal samples.<a href="#bib33" class="usa-link" aria-describedby="bib33"><sup>33</sup></a> Non-SCLC RNA-seq data were downloaded from the The Cancer Genome Atlas data portal (<a href="https://portal.gdc.cancer.gov/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://portal.gdc.cancer.gov/</a>). We randomly chose a subset of 60 and 49 tumor-normal paired samples of lung adenocarcinoma and squamous cell carcinoma, respectively, for ssGSEA and ImSig analyses.</p></section><section id="sec2.10"><h3 class="pmc_sec_title">Molecular Subtyping of SCLC Samples</h3>
<p id="p0075">SCLC subtype classification was performed after a previously published method.<a href="#bib34" class="usa-link" aria-describedby="bib34"><sup>34</sup></a> Briefly, the samples were classified on the basis of defining thresholds (log<sub>2</sub>[fragments per kilobase per million + 1]) for transcription factors <em>YAP1</em> (2.5) and <em>POU2F3</em> (2.5). Samples were classified as ASCL1 or NEUROD1 subtype on the basis of relative expression of these genes, with minimum required difference of 1. The above-mentioned method was unable to classify all samples included in this study; therefore, remaining samples were assigned to SCLC subtypes on the basis of the gene (<em>ASCL1</em>, <em>NEUROD1</em>, <em>YAP1</em>, or <em>POU2F3</em>) with highest expression (TPM) value. When expression difference was less than twofold between <em>ASCL1</em> and <em>NEUROD1</em>, samples were classified as dual-positive ASCL1/NEUROD1. <em>ARG2</em> expression between subtypes was compared using two-tailed unpaired <em>t</em> tests.</p></section><section id="sec2.11"><h3 class="pmc_sec_title">T Cell-Inflamed Gene Expression Profile Scores and Heatmaps</h3>
<p id="p0080">TPM values for genes in the housekeeping (n = 11) and predictor (n = 18) sets were converted into count-equivalent values, and gene expression profile (GEP) scores were computed as previously described<a href="#bib35" class="usa-link" aria-describedby="bib35"><sup>35</sup></a> and as detailed in the Supplementary Methods. Heatmaps of log-transformed TPM values of the 18 genes in the T cell-inflamed GEP were generated using Qlucore Omics Explorer (Qlucore AB) version 3.6.</p></section></section><section id="sec3"><h2 class="pmc_sec_title">Results</h2>
<p id="p0085">Demographic and clinical information of the five patients with SCLC who underwent research autopsy is presented in <a href="#tbl1" class="usa-link">Table 1</a>. All had metastatic SCLC at diagnosis and received multiple lines of treatments, including first-line cisplatin or carboplatin and etoposide as autopsies were performed before the approval of atezolizumab and durvalumab. All patients responded to first-line chemotherapy but relapsed within 1 to 5 months of completing the last treatment cycle. Three patients received immunotherapy subsequently but were nonresponders. The time from diagnosis to death ranged from 12 to 25 months. Numerous metastatic tumors from four to five different organs were procured through autopsy of each patient. A total of 60 metastatic tumor samples were selected for whole-exome sequencing (WES) and 30 tumor samples for RNA-seq (<a href="#appsec1" class="usa-link">Supplementary Data 1</a>). Pretreatment samples were included for WES and RNA-seq when available. Matched normal lung tissue was available for RNA-seq from two autopsy patients (<a href="#appsec1" class="usa-link">Supplementary Data 1</a>).</p>
<section class="tw xbox font-sm" id="tbl1"><h3 class="obj_head">Table 1.</h3>
<div class="caption p"><p>Demographics and Clinical Histories of Relapsed Small Cell Lung Cancer (SCLC) Patients Who Underwent Research Autopsy</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1">SCLC 1</th>
<th colspan="1" rowspan="1">SCLC 2</th>
<th colspan="1" rowspan="1">SCLC 3</th>
<th colspan="1" rowspan="1">SCLC 4</th>
<th colspan="1" rowspan="1">SCLC 5</th>
</tr></thead>
<tbody>
<tr>
<td colspan="1" rowspan="1"><em>Gender</em></td>
<td colspan="1" rowspan="1">Female</td>
<td colspan="1" rowspan="1">Female</td>
<td colspan="1" rowspan="1">Male</td>
<td colspan="1" rowspan="1">Male</td>
<td colspan="1" rowspan="1">Female</td>
</tr>
<tr>
<td colspan="1" rowspan="1"><em>Age</em></td>
<td colspan="1" rowspan="1">59</td>
<td colspan="1" rowspan="1">54</td>
<td colspan="1" rowspan="1">75</td>
<td colspan="1" rowspan="1">62</td>
<td colspan="1" rowspan="1">64</td>
</tr>
<tr>
<td colspan="1" rowspan="1"><em>Ethnicity</em></td>
<td colspan="1" rowspan="1">Caucasian</td>
<td colspan="1" rowspan="1">Caucasian</td>
<td colspan="1" rowspan="1">Caucasian</td>
<td colspan="1" rowspan="1">Caucasian</td>
<td colspan="1" rowspan="1">Caucasian</td>
</tr>
<tr>
<td colspan="1" rowspan="1"><em>Smoking (pack years)</em></td>
<td colspan="1" rowspan="1">60</td>
<td colspan="1" rowspan="1">20</td>
<td colspan="1" rowspan="1">60</td>
<td colspan="1" rowspan="1">45</td>
<td colspan="1" rowspan="1">47</td>
</tr>
<tr>
<td colspan="1" rowspan="1"><em>Stage at diagnosis</em></td>
<td colspan="1" rowspan="1">Extensive</td>
<td colspan="1" rowspan="1">Extensive</td>
<td colspan="1" rowspan="1">Extensive</td>
<td colspan="1" rowspan="1">Extensive</td>
<td colspan="1" rowspan="1">Extensive</td>
</tr>
<tr>
<td colspan="1" rowspan="1"><em>Radiation</em></td>
<td colspan="1" rowspan="1">PCI<a href="#tbl1fna" class="usa-link"><sup>a</sup></a> and palliative</td>
<td colspan="1" rowspan="1">PCI</td>
<td colspan="1" rowspan="1">PCI</td>
<td colspan="1" rowspan="1">Palliative</td>
<td colspan="1" rowspan="1">PCI</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<em>1</em><sup><em>st</em></sup><em>line therapy</em>
</td>
<td colspan="1" rowspan="1">Cisplatin &amp; etoposide x6</td>
<td colspan="1" rowspan="1">Carboplatin &amp; etoposide x4</td>
<td colspan="1" rowspan="1">Cisplatin &amp; etoposide x6</td>
<td colspan="1" rowspan="1">Carboplatin &amp; etoposide x4</td>
<td colspan="1" rowspan="1">Carboplatin &amp; etoposide x4</td>
</tr>
<tr>
<td colspan="1" rowspan="1"><em>Best response to platinum</em></td>
<td colspan="1" rowspan="1">PR<a href="#tbl1fnb" class="usa-link"><sup>b</sup></a>
</td>
<td colspan="1" rowspan="1">Mild/mixed response</td>
<td colspan="1" rowspan="1">PR</td>
<td colspan="1" rowspan="1">PR</td>
<td colspan="1" rowspan="1">PR</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
<em>Subsequent therapies</em><br><em>received</em>
</td>
<td colspan="1" rowspan="1">Topotecan</td>
<td colspan="1" rowspan="1">Irinotecan<br>Rova-T<a href="#tbl1fnc" class="usa-link"><sup>c</sup></a><br>Paclitaxel</td>
<td colspan="1" rowspan="1">Irinotecan<br>Nivolumab</td>
<td colspan="1" rowspan="1">Immunotherapy<a href="#tbl1fnd" class="usa-link"><sup>d</sup></a><br>Irinotecan</td>
<td colspan="1" rowspan="1">Immunotherapy<a href="#tbl1fnd" class="usa-link"><sup>d</sup></a><br>Irinotecan<br>Rova-T<a href="#tbl1fnc" class="usa-link"><sup>c</sup></a><br>Paclitaxel<br>Gemcitabine</td>
</tr>
<tr>
<td colspan="1" rowspan="1"><em>Time from diagnosis to death</em></td>
<td colspan="1" rowspan="1">23 months</td>
<td colspan="1" rowspan="1">12 months</td>
<td colspan="1" rowspan="1">25 months</td>
<td colspan="1" rowspan="1">12 months</td>
<td colspan="1" rowspan="1">22 months</td>
</tr>
<tr>
<td colspan="1" rowspan="1"><em># Metastatic tumors (# organs) collected at autopsy</em></td>
<td colspan="1" rowspan="1">25 (5)</td>
<td colspan="1" rowspan="1">17 (5)</td>
<td colspan="1" rowspan="1">14 (4)</td>
<td colspan="1" rowspan="1">21 (5)</td>
<td colspan="1" rowspan="1">16 (4)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="fn1"><p>Note: All patients had extensive smoking history, metastatic disease at time of diagnosis, received standard of care platinum-doublet chemotherapy, radiation therapy, and had partial response except for one patient. All patients received more than one line of therapy, including experimental therapies on clinical trials as indicated in the footnote. Patients who received experimental therapies were non-responders.</p></div>
<div class="fn" id="tbl1fna">
<sup>a</sup><p class="display-inline" id="ntpara0010aa">Prophylactic cranial irradiation</p>
</div>
<div class="fn" id="tbl1fnb">
<sup>b</sup><p class="display-inline" id="ntpara0015bb">Partial response</p>
</div>
<div class="fn" id="tbl1fnc">
<sup>c</sup><p class="display-inline" id="ntpara0020cc">Clinical trial <a href="https://clinicaltrials.gov/ct2/show/NCT02674568" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT02674568</a><strong>:</strong> Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer (TRINITY)</p>
</div>
<div class="fn" id="tbl1fnd">
<sup>d</sup><p class="display-inline" id="ntpara0025">Clinical trial <a href="https://clinicaltrials.gov/ct2/show/NCT02538666" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT02538666</a><strong>:</strong> An Investigational Immuno-therapy Study of Nivolumab, or Nivolumab in Combination with Ipilimumab, or Placebo in Patients with Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) After Completion of Platinum-based Chemotherapy (CheckMate 451)</p>
</div>
</div></section><section id="sec3.1"><h3 class="pmc_sec_title">Genomic Alterations in Relapsed SCLC</h3>
<p id="p0090">WES revealed high tumor mutational burden (TMB) in our SCLC tumor samples, ranging from 5.7 to 29.8 mutations per megabase of genome (<a href="#appsec1" class="usa-link">Supplementary Data 2–6</a>). The percentage of private somatic variants, or those present in only one tumor sample, in patients 1 to 5 ranged from 32% to 56%, suggesting high intertumoral heterogeneity (<a href="#appsec1" class="usa-link">Supplementary Fig. 1</a><em>A</em> and <em>B</em>). We assessed the identities of SMGs using MuSiC,<a href="#bib27" class="usa-link" aria-describedby="bib27"><sup>27</sup></a> finding <em>TP53</em> as the top SMG mutated in 100% of the tumor samples (<a href="#fig1" class="usa-link">Fig. 1</a><em>A</em>). Additional SMGs included <em>LRP1B</em>, <em>RYR2</em>, and <em>USH2A</em> (<a href="#fig1" class="usa-link">Fig. 1</a><em>A</em> and <a href="#appsec1" class="usa-link">Supplementary Data 7</a>). We sought to determine whether these genes may be preferentially mutated in SCLC relative to other cancer types by assessing their alteration frequency in The Cancer Genome Atlas PanCancer Atlas studies (&gt;10,000 samples) and 210 predominantly primary SCLC samples<a href="#bib7" class="usa-link" aria-describedby="bib7">7</a>, <a href="#bib8" class="usa-link" aria-describedby="bib8">8</a>, <a href="#bib9" class="usa-link" aria-describedby="bib9">9</a><sup>,</sup><a href="#bib13" class="usa-link" aria-describedby="bib13"><sup>13</sup></a> through cBioPortal for Cancer Genomics.<a href="#bib36" class="usa-link" aria-describedby="bib36"><sup>36</sup></a><sup>,</sup><a href="#bib37" class="usa-link" aria-describedby="bib37"><sup>37</sup></a> This analysis revealed a high-alteration frequency of these genes in SCLC but also in other cancer types with high TMB (<a href="#appsec1" class="usa-link">Supplementary Fig. 2</a><em>A</em> and <em>B</em>).</p>
<figure class="fig xbox font-sm" id="fig1"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8474405_gr1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d52/8474405/3257d919381a/gr1.jpg" loading="lazy" height="1037" width="759" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Identification of SMGs and CNVs in SCLC autopsy patients. (<em>A</em>) Oncoplot of SMGs identified in our SCLC cohort using MuSiC (FDR &lt; 0.05). Multiple tumor samples per patient with SCLC were sequenced, resulting in exome data from 63 samples including three pretreatment biopsy samples (marked by ∗). Vertical bar graphs (top) reveal total number of Mut. per corresponding tumor sample below. Horizontal bar graphs and percentages (left) reveal mutational frequency of the corresponding gene (right). Type of somatic variant is defined by colored box key at the bottom, with black boxes indicating multiple variants detected in a specific gene in a given tumor sample. (<em>B</em>) Uncurated CNVs in SCLC autopsy patients detected by FALCON. Data from all tumor samples per patient were pooled into a composite CNV profile as illustrated for each patient. Gains were defined as allele number greater than 2.0 (e.g., <em>SOX2</em>) and loss less than 0.5 (e.g., <em>APC</em>). Red line, major allele. Blue line, minor allele. Green line, no change in one or both alleles. CNV, copy number variation; FDR, false discovery rate; Mut., mutation; SMG, significantly mutated gene. #, number.</p></figcaption></figure><p id="p0095">We detected an <em>RB1</em> E204X nonsense mutation in a subset of tumor samples in patient 5 (<a href="#appsec1" class="usa-link">Supplementary Data 6</a>), and <em>PTEN</em> mutations in patients 1 and 3. In patient 1, <em>PTEN</em> C105F (a validated driver variant) was present in all metastatic tumor samples except for a residual primary right lung tumor and three brain metastases (<a href="#appsec1" class="usa-link">Supplementary Data 2</a>). In patient 3, <em>PTEN</em> Y46N was present in a single metastatic tumor sample (<a href="#appsec1" class="usa-link">Supplementary Data 4</a>).</p></section><section id="sec3.2"><h3 class="pmc_sec_title">CNVs in Relapsed SCLC</h3>
<p id="p0100">We identified a high frequency of CNVs using FALCON<a href="#bib24" class="usa-link" aria-describedby="bib24"><sup>24</sup></a> in all SCLC tumor samples from the five autopsy patients (<a href="#fig1" class="usa-link">Fig. 1</a><em>B</em>, <a href="#appsec1" class="usa-link">Supplementary Data 8</a>). All patients had monoallelic loss, defined as allele copy less than 0.5, of chromosome 17p regions containing <em>TP53</em>. We also detected monoallelic loss of chromosome 13q regions containing <em>RB1</em> in patients 2, 3, and 5. Notably, tumor samples from all five patients had monoallelic deletions of a region on chromosome 5q containing <em>APC</em>. Consistent with previous studies,<a href="#bib8" class="usa-link" aria-describedby="bib8"><sup>8</sup></a> we detected allele-specific gains, defined as allele copy greater than 2, of chromosome 3q regions containing <em>SOX2</em> in patients 1, 3, and 5; and 8q regions containing <em>MYC</em> in patients 1, 3, and 4.</p></section><section id="sec3.3"><h3 class="pmc_sec_title">Clonal Heterogeneity and Evolution in Relapsed SCLC</h3>
<p id="p0105">We used the tool CANOPY<a href="#bib25" class="usa-link" aria-describedby="bib25"><sup>25</sup></a> to integrate single-nucleotide variant (SNVs), indels, and curated CNVs (<a href="#appsec1" class="usa-link">Supplementary Fig. 2</a><em>C</em>) to infer clonal diversity and architecture in advanced SCLC.<a href="#bib18" class="usa-link" aria-describedby="bib18"><sup>18</sup></a> Between 5 and 8 genetically distinct tumor cell clones were inferred to exist in each patient (<a href="#fig2" class="usa-link">Figs. 2</a><em>A</em>–D and 3<em>A</em>, <a href="#appsec1" class="usa-link">Supplementary Data 9</a>). <em>TP53</em> and <em>RB1</em> mutations were classified as truncal in all patients. Mutations in epigenetic modifiers such as <em>CREBBP</em> and <em>HDAC2</em> were also truncal, along with <em>APC</em> (5q) deletion in a subset of patients. Subclonal alterations included <em>PTEN</em> deletion and mutations and <em>MYC</em> amplification. We used CHASM<a href="#bib28" class="usa-link" aria-describedby="bib28"><sup>28</sup></a> to identify predicted driver mutations in Wnt pathway genes such as <em>XPO1</em> and <em>AXIN1</em> (<a href="#appsec1" class="usa-link">Supplementary Data 10</a>). We used Bradley-Terry models<a href="#bib18" class="usa-link" aria-describedby="bib18"><sup>18</sup></a> to approximate the temporal occurrence of clonal and subclonal alterations and found that truncal alterations in <em>TP53</em>, <em>RB1</em>, <em>CREBBP</em>, and <em>HDAC2</em> occurred early, consistent with the critical role of these tumor suppressors in SCLC biology (<a href="#appsec1" class="usa-link">Supplementary Data 11</a>). Finally, we used deconstructSigs<a href="#bib26" class="usa-link" aria-describedby="bib26"><sup>26</sup></a> to analyze mutational signatures and found truncal signature 4, which is associated with tobacco smoking.<a href="#bib38" class="usa-link" aria-describedby="bib38"><sup>38</sup></a></p>
<figure class="fig xbox font-sm" id="fig2"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8474405_gr2.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d52/8474405/5cd86af0767f/gr2.jpg" loading="lazy" height="779" width="739" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Inferred clonal phylogeny and heterogeneity in four SCLC autopsy patients. (<em>A–D</em>) (Left) Tumor samples procured from research autopsy as labeled on the human figure. Three large tumors from SCLC1 and SCLC3 were divided into multiple regions for sequencing. (<em>A–D</em>) (Middle) Phylogenetic trees depicting clonal evolution from a normal cell (gray solid circle) are as illustrated, with branch length corresponding to mutational burden. Numbers in parentheses after genes reveal predicted order of occurrence in a truncal branch (e.g., <em>A</em>, <em>CREBBP</em>, third mut. to occur of 273 truncal alterations). The COSMIC tobacco mut. Sig.4 was detected in the trunk of all five phylogenetic trees. Clonal and subclonal predicted driver mut., indicated by ∗, in Wnt signaling genes include <em>CREBBP</em> and <em>TRRAP</em> in (<em>A</em>) SCLC1, (<em>B</em>) <em>FZD</em> in SCLC2, <em>DVL1</em>, and (<em>C</em>) <em>XPO1</em> in SCLC3, and (<em>D</em>) <em>AXIN1</em> in SCLC4. (<em>A–D</em>) (Right) Percentage of different clones that compose each tumor sample are as revealed, demonstrating increased clonal heterogeneity. #T1, residual primary tumor in SCLC1; Adr., adrenal; Bx, pretreatment biopsy; del, deletion; Liv., liver; LN, lymph node; LOH, loss of heterozygosity; Lu, lung; mut., mutation; Sig., signature.</p></figcaption></figure><p id="p0110">We next evaluated spatiotemporal clonal heterogeneity in advanced SCLC. In patient 1, we identified a tumor cell clone (clone 4) unique to brain metastases (T3–5) and the remnant primary tumor (∗T1) (<a href="#fig2" class="usa-link">Fig. 2</a><em>A</em>). In patient 2, the biopsy and posttreatment samples had similar clonal compositions (<a href="#fig2" class="usa-link">Fig. 2</a><em>B</em>). In patient 3, clone 5 in the biopsy sample decreased substantially in all but three (T7–9) posttreatment tumors corresponding to the brain and upper lung (<a href="#fig2" class="usa-link">Fig. 2</a><em>C</em>). Conversely, clone 6 in the biopsy sample substantially increased in a subset of posttreatment tumors, particularly in the lymph node samples T10 to 12. In patient 4, clone 3 harboring a <em>BRCA2</em> G620E mutation decreased considerably in all posttreatment tumor samples (T1–12) (<a href="#fig2" class="usa-link">Fig. 2</a><em>D</em>), consistent with the well-characterized platinum-sensitizing effects of <em>BRCA</em> mutations. Furthermore, posttreatment tumors had increased proportions of clones 4 to 6 that contained predicted driver alterations by CHASM in the Wnt pathway (<em>AXIN1</em> mutation, <em>APC</em> deletion), which has been associated with chemoresistance.<a href="#bib14" class="usa-link" aria-describedby="bib14"><sup>14</sup></a></p>
<p id="p0115">Finally, in patient 5, we identified a tumor cell clone (clone 5) present at increased proportions in all six liver metastases (T6–11; <a href="#fig3" class="usa-link">Fig. 3</a><em>A</em>). In addition, ctDNA was isolated from the plasma of this patient shortly before death and subjected to WES (Supplementary Data 12). We determined high concordance (<em>p</em> &lt; 10<sup>−5</sup>) between ubiquitous tumor variants and ctDNA variants, including SNVs (<a href="#fig3" class="usa-link">Fig. 3</a><em>B</em>, <a href="#appsec1" class="usa-link">Supplementary Fig. 3</a><em>A</em>) and indels (<a href="#appsec1" class="usa-link">Supplementary Fig. 3</a><em>B</em> and <em>C</em>). To infer the abundance of clones identified from autopsy in ctDNA, we used a maximum likelihood approach that revealed similar clonal composition between ctDNA (ctDNA, <a href="#fig3" class="usa-link">Fig. 3</a><em>A</em>) and liver metastases, thus suggesting this patient’s hepatic tumor burden preferentially contributed to ctDNA.</p>
<figure class="fig xbox font-sm" id="fig3"><h4 class="obj_head">Figure 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8474405_gr3.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d52/8474405/a1cf478556af/gr3.jpg" loading="lazy" height="479" width="740" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Concordance between ctD (ctDNA) and tumor profiling in a fifth SCLC autopsy patient. (<em>A</em>) Inferred clonal phylogeny and clonal composition of metastatic tumors from a fifth SCLC autopsy patient. Truncal predicted driver alterations include point mut. in <em>RB1</em> and Wnt pathway gene <em>PSMC1</em> and copy number losses of <em>TP53</em> and <em>APC</em>. Tumor clonal heterogeneity was recapitulated in a ctD sample collected shortly before death of this patient. The ctD sample revealed a high proportion of clone 5, which was detected in increased proportions only in liver metastases T6 to T11. (<em>B</em>) (Left) Bar graph reveals concordant numbers of SNVs between tumor and ctD. (Right) Average VAF of Ubi. SNVs was compared with VAF of ctD variants. amp, amplification; ctD, circulating tumor DNA; del, deletion; mut., mutation; Sig., signature; SNV, single-nucleotide variant; Ubi., ubiquitous; VAF, variant allele frequency. #: number.</p></figcaption></figure></section><section id="sec3.4"><h3 class="pmc_sec_title">RNA-Seq Reveals Decreased Antitumor Immunity in Advanced SCLC</h3>
<p id="p0120">To further characterize advanced SCLC, we performed transcriptome sequencing on a subset of tumor samples from each SCLC autopsy patient (Supplementary Data 1). Given the limited number of matched lung normal and pretreatment/primary SCLC tumors in our data set, we incorporated additional publicly available SCLC RNA-seq data sets<a href="#bib8" class="usa-link" aria-describedby="bib8"><sup>8</sup></a><sup>,</sup><a href="#bib14" class="usa-link" aria-describedby="bib14"><sup>14</sup></a><sup>,</sup><a href="#bib15" class="usa-link" aria-describedby="bib15"><sup>15</sup></a><sup>,</sup><a href="#bib33" class="usa-link" aria-describedby="bib33"><sup>33</sup></a> into all subsequent analyses. Two external SCLC data sets combined had 31 relapsed and three pretreatment samples,<a href="#bib14" class="usa-link" aria-describedby="bib14"><sup>14</sup></a><sup>,</sup><a href="#bib15" class="usa-link" aria-describedby="bib15"><sup>15</sup></a> one data set contained 30 primary SCLC and 25 matched normal samples,<a href="#bib8" class="usa-link" aria-describedby="bib8"><sup>8</sup></a> and one data set contained eight normal lung samples.<a href="#bib33" class="usa-link" aria-describedby="bib33"><sup>33</sup></a> We first performed ssGSEA<a href="#bib31" class="usa-link" aria-describedby="bib31"><sup>31</sup></a> using gene sets from the NanoString Tumor Signaling 360 panel (<a href="#appsec1" class="usa-link">Supplementary Data 13</a>). Intriguingly, most SCLC samples had decreased enrichment of pathways related to antitumor immune response: “avoiding immune destruction” and “tumor-promoting inflammation” compared with normal samples (<a href="#appsec1" class="usa-link">Supplementary Fig. 4</a><em>A</em>).</p>
<p id="p0125">To delineate how the immune tumor microenvironment (TME) may be altered in SCLC, we next performed ssGSEA using the NanoString PanCancer Immuno-Oncology 360 panel. This revealed decreased enrichment (<em>p</em> &lt; 0.001) of processes annotated with adaptive antitumor immune function and immuno-metabolism in SCLC tumors relative to normal tissue (<a href="#fig4" class="usa-link">Fig. 4</a><em>A</em>, <a href="#appsec1" class="usa-link">Supplementary Data 13</a>). We also used ImSig<a href="#bib32" class="usa-link" aria-describedby="bib32"><sup>32</sup></a> to interrogate immune cell subsets in the SCLC TME, which revealed low gene expression signatures of T cells and innate immune cells in primary and relapsed SCLC tumors (<a href="#fig4" class="usa-link">Fig. 4</a><em>B</em>, <a href="#appsec1" class="usa-link">Supplementary Data 13</a>). Finally, we repeated ssGSEA and ImSig on our own research autopsy data set, in addition to the above-mentioned analyses of pooled data sets, and confirmed these results (<a href="#appsec1" class="usa-link">Supplementary Fig. 4</a><em>B</em> and <em>C</em>).</p>
<figure class="fig xbox font-sm" id="fig4"><h4 class="obj_head">Figure 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8474405_gr4.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d52/8474405/1d125a9d3587/gr4.jpg" loading="lazy" height="453" width="742" alt="Figure 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Transcriptome analyses reveal decreased expression of genes involved in antitumor immune responses in SCLC. (<em>A</em>) Box plots of ESs from ssGSEA analysis of gene sets derived from NanoString PanCancer IO 360 panel. Statistically significant differences in ES were detected in pairwise comparisons between normal-primary and normal-relapse. ∗, adjusted <em>p</em> &lt; 0.0001. (<em>B</em>) Box plots of ImSig scores for different immune cell types in the adaptive and innate immune systems. Statistically significant differences in ES were detected in pairwise comparisons between normal-primary and normal-relapse. ∗, adjusted <em>p</em> &lt; 0.0001. ES, enrichment score; ImSig, Immune signature; IO, Immune-Oncology; Mac., macrophage; Mono., monocyte; Neutro., neutrophil; NK, natural killer; Pretx, pretreatment; sig., signature; ssGSEA, single-sample gene set enrichment.</p></figcaption></figure><p id="p0130">T cells are key mediators of the adaptive antitumor immune response and targets of immune checkpoint inhibitors (ICIs). Given that ssGSEA and ImSig results indicated decreased T cell presence in the SCLC TME, we further interrogated expression of 18 genes in the analytically validated T cell-inflamed GEP, which was developed as a predictor of clinical benefit to ICI in multiple cancer types.<a href="#bib39" class="usa-link" aria-describedby="bib39"><sup>39</sup></a> Responders to ICI were reported to have pretreatment baseline tumors with higher GEP scores (hot), whereas nonresponders had tumors with lower baseline GEP scores (cold).<a href="#bib35" class="usa-link" aria-describedby="bib35"><sup>35</sup></a><sup>,</sup><a href="#bib39" class="usa-link" aria-describedby="bib39"><sup>39</sup></a> Hierarchical clustering (<a href="#fig5" class="usa-link">Fig. 5</a><em>A</em>, <em>p</em> = 0.05) and calculation of GEP scores in the pooled (<a href="#fig5" class="usa-link">Fig. 5</a><em>B</em>) and autopsy only (<a href="#appsec1" class="usa-link">Supplementary Fig. 5</a><em>A</em>) data sets revealed that most primary and relapsed SCLC are cold relative to either matched tissue normal or non-SCLC subtypes of adenocarcinoma and squamous cell carcinoma (<a href="#appsec1" class="usa-link">Supplementary Fig. 5</a><em>B</em>, <a href="#appsec1" class="usa-link">Supplementary Data 14</a>). Only five SCLC tumors were inflamed and had GEP scores higher than the median score of −0.09 in normal samples (<a href="#appsec1" class="usa-link">Supplementary Data 15</a>).</p>
<figure class="fig xbox font-sm" id="fig5"><h4 class="obj_head">Figure 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8474405_gr5.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d52/8474405/d5e5a79638de/gr5.jpg" loading="lazy" height="1042" width="776" alt="Figure 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>T cell-inflamed GEP evaluation reveals different immune phenotypes in neuroendocrine versus non-neuroendocrine SCLC. (<em>A</em>) Heatmap of log-transformed expression values (TPM) of genes representing the analytically validated T cell-inflamed GEP. Hierarchical clustering was performed using Qlucore Omics Explorer v3.6. Most primary and relapsed SCLC tumor samples revealed low GEP expression relative to normal lung tissue. Sample type and data source indicated as labeled. (<em>B</em>) Violin plot of GEP scores for normal, primary, and relapsed SCLC samples. Higher scores indicate “hot” tumors, whereas lower scores indicate “cold” tumors. Two-tailed unpaired <em>t</em> test ∗<em>p</em> &lt; 0.001; ∗∗<em>p</em> &lt; 0.01. (<em>C</em>) Violin plot of TPM values of selected T cell-inflamed GEP and checkpoint genes in normal and SCLC tumor samples. (<em>D</em>) Heatmap of log-transformed expression values (TPM) of T cell-inflamed GEP genes in SCLC tumor samples annotated by subtype and data source as indicated. (<em>E</em>) Violin plot of GEP scores in different subtypes of SCLC and normal lung. Each subtype was compared against normal using two-tailed unpaired <em>t</em> test ∗, <em>p</em> &lt; 0.01. (<em>F</em>) Violin plot of <em>IDO1/2</em> and <em>ARG1/2</em> expression in normal, primary, and relapsed SCLC. Primary/pretx or relapsed samples were compared against normal using two-tailed unpaired <em>t</em> test ∗<em>p</em> &lt; 0.001; ∗∗<em>p</em> &lt; 0.005. (<em>G</em>) Violin plot of <em>ARG2</em> expression in SCLC tumor samples annotated by subtype. Each subtype was compared against normal using two-tailed unpaired <em>t</em> test. ∗<em>p</em> &lt; 0.001; ∗∗<em>p</em> &lt; 0.005. ARG, arginase; GEP, gene expression profile; IDO, indoleamine 2,3-dioxygenase; Pretx, pretreatment; TPM, transcript reads per million.</p></figcaption></figure><p id="p0135">As atezolizumab and durvalumab are both programmed death-ligand 1 (PD-L1) monoclonal antibodies approved in combination with chemotherapy in advanced SCLC, we evaluated the expression of PD-L1 (<em>CD274</em>). <em>CD274</em> expression was low in most primary and relapsed SCLC samples (<a href="#fig5" class="usa-link">Fig. 5</a><em>C</em>, <a href="#appsec1" class="usa-link">Supplementary Fig. 5</a><em>C</em>), consistent with previous analyses revealing that only a few patients (∼20%) with SCLC had tumors with PD-L1 protein expression greater than 1%.<a href="#bib40" class="usa-link" aria-describedby="bib40"><sup>40</sup></a> In contrast to <em>CD274</em>, the expression of immune checkpoint inhibitory ligands <em>CD276</em> (<em>B7-H3</em>) and <em>CD200</em> was increased in most SCLC tumor samples (<a href="#fig5" class="usa-link">Fig. 5</a><em>C</em>, <a href="#appsec1" class="usa-link">Supplementary Fig. 5</a><em>C</em>). Consistent with ImSig revealing a lack of T cell signature in their TME, SCLC tumor samples had low expression levels of <em>CTLA4</em>, <em>TIGIT</em>, and other immune checkpoint molecules found on T cells (<a href="#fig5" class="usa-link">Fig. 5</a><em>C</em>, <a href="#appsec1" class="usa-link">Supplementary Fig. 5</a><em>C</em>). Fially, interrogation of 50 SCLC cell lines from the Cancer Cell Line Encyclopedia recapitulated these gene expression patterns of <em>CD276</em>, <em>CD200</em>, and <em>CD274</em> (<a href="#appsec1" class="usa-link">Supplementary Fig. 5</a><em>D</em>, <a href="#appsec1" class="usa-link">Supplementary Data 14</a>).</p>
<p id="p0140">We further evaluated whether the four SCLC subtypes, as defined by the expression of <em>ASCL1</em>, <em>NEUROD1</em>, <em>YAP1</em>, and <em>POU2F3</em> using a previously described method<a href="#bib10" class="usa-link" aria-describedby="bib10"><sup>10</sup></a> (<a href="#appsec1" class="usa-link">Supplementary Fig. 6</a>) and on the basis of highest gene expression evaluation (Supplementary Data 16), may have different immune phenotypes. As expected, most (n = 56 of 94) SCLC samples were <em>ASCL1</em>-high, whereas tumors with high expression of <em>ASCL1/NEUROD1</em> (n = 11), <em>NEUROD1</em> (n = 13), <em>YAP1</em> (n = 6), and <em>POU2F3</em> (n = 8) were the minority. Hierarchical clustering revealed that the non-neuroendocrine SCLC subtypes, <em>YAP1</em> and <em>POU2F3</em>, had more tumors with elevated T cell-inflamed GEP whereas the classic and variant neuroendocrine subtypes were associated with predominantly low GEP (<a href="#fig5" class="usa-link">Fig. 5</a><em>D</em>). When GEP scores were calculated for each subtype,<a href="#bib35" class="usa-link" aria-describedby="bib35"><sup>35</sup></a>
<em>YAP1</em> and <em>POU2F3</em> tumors had GEP scores closer to that of normal lung tissue (<a href="#fig5" class="usa-link">Fig. 5</a><em>E</em>). <em>ImSig</em> analysis further revealed that <em>YAP1</em> tumors, although limited in sample size, are particularly associated with increased T cell and innate immune cell signatures (<a href="#appsec1" class="usa-link">Supplementary Fig. 7</a>).</p>
<p id="p0145">Finally, to extend our analysis of suppressed immune function in SCLC, we interrogated expression of immunometabolism genes (<a href="#fig4" class="usa-link">Fig. 4</a><em>A</em>) encoding indoleamine 2,3-dioxygenase and arginase (ARG)1/2 enzymes (<a href="#fig5" class="usa-link">Fig. 5</a><em>F</em>), whose metabolic function have been reported to inhibit effector T cell and natural killer cell activity.<a href="#bib41" class="usa-link" aria-describedby="bib41">41</a>, <a href="#bib42" class="usa-link" aria-describedby="bib42">42</a>, <a href="#bib43" class="usa-link" aria-describedby="bib43">43</a> Of the four genes, only <em>ARG2</em> expression was significantly increased in primary and relapsed SCLC tumors (<a href="#fig5" class="usa-link">Fig. 5</a><em>F</em>) and cell lines (<a href="#appsec1" class="usa-link">Supplementary Fig. 5</a><em>D</em>). We then evaluated <em>ARG2</em> expression on the basis of SCLC subtypes (<a href="#fig5" class="usa-link">Fig. 5</a><em>G</em>) and in NSCLC (<a href="#appsec1" class="usa-link">Supplementary Fig. 8</a><em>A</em> and <em>B</em>). This analysis revealed high <em>ARG2</em> expression in the neuroendocrine SCLC subtypes (<em>ASCL1</em>, <em>ASCL1/NEUROD1</em>, and <em>NEUROD1</em>) and low <em>ARG2</em> expression in the non-neuroendocrine subtypes (<em>YAP1</em> and <em>POU2F3</em>) (<a href="#fig5" class="usa-link">Fig. 5</a><em>G</em>) and low <em>ARG2</em> expression in NSCLC (<a href="#appsec1" class="usa-link">Supplementary Fig. 8</a><em>B</em>). Taken together, these results support the need to further investigate <em>ARG2</em> as a potential negative regulator of immune TME in the most common neuroendocrine SCLC subtypes.</p></section></section><section id="sec4"><h2 class="pmc_sec_title">Discussion</h2>
<p id="p0150">In this study, we leveraged rapid research autopsy to perform genomic and transcriptomic characterization of advanced SCLC. Our results revealed substantial clonal heterogeneity in relapsed SCLC, arising through branched evolution. We identified numerous subclonal alterations likely underlying treatment sensitivity, thus explaining the expansion or reduction of specific clones in tumors at different metastatic sites in each patient. Although limited in sample size, our results revealed that certain clones are enriched in metastatic sites such as the brain and liver, with the liver as the main ctDNA contributor in one patient. The ability to detect tissue-specific clones may have certain clinical use. For example, the central nervous system (CNS) is a frequent site of metastasis in patients with SCLC. The presence of brain-specific subclonal alterations in the ctDNA may help predict which patients are at highest risk for CNS disease and therefore be considered for prophylactic cranial irradiation or novel therapies to prevent CNS disease. Our study demonstrates the use of autopsy in studying subclone preference for specific metastatic niches, which will require additional autopsies of patients with SCLC and other solid tumors.</p>
<p id="p0155">In addition to identifying <em>TP53</em> as the top SMG and inferring <em>TP53</em> mutations as truncal drivers in all autopsy patients, we also identified multiple mutations in <em>LRP1B</em>, which has putative tumor-suppressor functions.<a href="#bib44" class="usa-link" aria-describedby="bib44">44</a>, <a href="#bib45" class="usa-link" aria-describedby="bib45">45</a>, <a href="#bib46" class="usa-link" aria-describedby="bib46">46</a> These truncal alterations raise the possibility that <em>LRPB1</em>-mutant tumor cells may acquire an early fitness advantage over wild-type cells, which is further supported by an increased frequency of <em>LRP1B</em> mutations in primary SCLC tumor samples (<a href="#appsec1" class="usa-link">Supplementary Fig. 1</a><em>A</em>). Thus, we propose that functional validation of variants in this gene and others (e.g., <em>RYR2</em>, <em>USH2A</em>) in appropriate model systems may begin to unravel their roles in the biology of SCLC and potentially other cancers.</p>
<p id="p0160">Alterations in the Wnt signaling pathway have been linked to acquired chemoresistance in relapsed SCLC.<a href="#bib14" class="usa-link" aria-describedby="bib14"><sup>14</sup></a> In a cohort of 30 relapsed SCLC samples, loss of heterozygosity of either <em>APC</em> or <em>CDH8</em> was detected in 23 of 30 samples, whereas mutations in either gene were detected in 10 of 30 samples. In our autopsy cohort, we identified copy number loss of <em>APC</em> as truncal or very early subclonal events in patients 1 to 3. We found truncal (<em>PSMC1</em>) and multiple subclonal (<em>TRRAP</em>, <em>FZD2</em>, and <em>XPO1</em>) predicted driver mutations in other Wnt signaling pathway genes. For instance, in patient 3, the autopsy tumor samples were enriched for clones C6 to C8 containing an <em>XPO1</em> mutation. In patient 4, mutation of another Wnt signaling gene, <em>AXIN1</em>, was assigned to a clone of tumor cells (C4) exclusively detected in posttreatment autopsy tumor samples. Therefore, our results are consistent with and support the established association between Wnt pathway and early chemoresistance in advanced SCLC.</p>
<p id="p0165">Analysis of ctDNA in patients with advanced SCLC represents a valuable approach to tracking tissue-specific clones or emergence of resistant clones.<a href="#bib47" class="usa-link" aria-describedby="bib47"><sup>47</sup></a> Although most studies have compared ctDNA with either a single primary or metastatic tumor biopsy, rapid autopsy enables the comparison of variants detected in ctDNA against variants in multiple metastatic tumors. In our study, we performed WES of ctDNA from patient 5 and detected nearly all ubiquitous tumor variants from autopsy that likely represented most of this patient’s truncal variants (concordance 97%–100% for SNVs and indels). Not surprisingly, for variants that were classified as shared or private at autopsy (e.g., subclonal variants), the metastatic tumor-ctDNA concordance rates were much lower. Therefore, our results reveal effective detection of truncal variants in ctDNA, but considerable limitations for detecting subclonal variants. These data and future autopsy studies will provide important contributions toward refining the limits of ctDNA detection for clinical applications, including the evaluation of minimal residual disease and cancer recurrence.</p>
<p id="p0170">Within our autopsy SCLC cohort, we performed transcriptome sequencing to evaluate whether mutations in SMGs may correlate with altered expression, thereby representing potential driver genes. However, this initial analysis did not reveal a significant correlation. In addition, consistent with previous studies revealing a paucity of gene fusions as drivers in SCLC,<a href="#bib48" class="usa-link" aria-describedby="bib48"><sup>48</sup></a> we did not detect any putative fusions that were recurrent in more than one tumor sample within our cohort. Recognizing that these results may be attributed to our limited cohort size, we incorporated external primary and relapsed SCLC RNA-seq data sets in subsequent analyses, which ultimately revealed suppressed immune TME in the neuroendocrine SCLC subtypes (<em>ASCL1</em>, <em>NEUROD1</em>, and <em>ASCL1/NEUROD1</em>).</p>
<p id="p0175">Given that only approximately 20% of patients with SCLC have tumors expressing PD-L1 (&gt;1% by immunohistochemistry),<a href="#bib40" class="usa-link" aria-describedby="bib40"><sup>40</sup></a> improved characterization of the SCLC immune TME remains an unmet need, particularly given recent regulatory approvals of frontline PD-L1 blockade therapy. Our results confirmed low <em>CD274</em> (PD-L1) expression in most SCLC tumors and cell lines, supporting the above-mentioned clinical observations. Additional ssGSEA and ImSig analyses corroborated decreased adaptive antitumor immune function in primary and relapsed SCLC. Although we lacked outcomes data to correlate with T cell-inflamed GEP scores, which predicts clinical benefit to programmed cell death protein 1/PD-L1 blockade,<a href="#bib39" class="usa-link" aria-describedby="bib39"><sup>39</sup></a> hierarchical clustering revealed a noninflamed phenotype in most primary and advanced SCLC. Interestingly, T cell-inflamed GEP expression was high, or close to that of normal lung samples, in non-neuroendocrine SCLC subtypes (<em>YAP1</em> and <em>POU2F3</em>) (<a href="#fig5" class="usa-link">Fig. 5</a><em>D</em>), which had low <em>ARG2</em> expression (<a href="#fig5" class="usa-link">Fig. 5</a><em>E</em>). In contrast, GEP expression was low in the neuroendocrine SCLC subtypes (<em>ASCL1</em>, <em>ASCL1/NEUROD1</em>, and <em>NEUROD1</em>), which had high <em>ARG2</em> expression. Given these observations, we hypothesize that increased ARG2 expression and function may represent a cell-autonomous oncogenic metabolic adaptation enabling suppression of adaptive antitumor immunity in the SCLC TME independent of PD-L1 expression. These results will need to be validated in larger, independent data sets but suggest that subtyping patients with SCLC before systemic treatment should aid in the identification of patients most likely to benefit from chemo-ICI. Finally, it was recently reported that the non-neuroendocrine SCLC subtypes were more likely to be admixed SCLC and NSCLC,<a href="#bib11" class="usa-link" aria-describedby="bib11"><sup>11</sup></a> which in addition to low <em>ARG2</em> expression may further explain the higher GEP scores and inflamed phenotype in these tumors given the responsiveness of NSCLC to ICI.</p>
<p id="p0180">Continuing the analysis of immune TME, in addition to decreased <em>CD274</em> expression, we reported decreased expression of <em>CTLA4</em>, <em>LAG3</em>, <em>TIM3</em>, and other well-characterized immune checkpoint proteins in advanced SCLC. Conversely, we detected increased expression of alternate checkpoint molecules, <em>CD276</em> (<em>B7-H3</em>) and <em>CD200</em>. CD276 is a member of the B7 family, which also includes PD-L1 (B7-H1). Consistent with our finding of increased gene expression, CD276 protein expression was recently detected in 64.9% of a SCLC cohort with 90 patients.<a href="#bib49" class="usa-link" aria-describedby="bib49"><sup>49</sup></a> The same study reported PD-L1 expression at a much lower rate of 7.3%.<a href="#bib49" class="usa-link" aria-describedby="bib49"><sup>49</sup></a> CD276 is expressed at low levels in normal tissues but when aberrantly expressed on various tumor cell types contributes to T cell inhibition, tumor cell immune evasion, and is associated with poor prognosis.<a href="#bib50" class="usa-link" aria-describedby="bib50"><sup>50</sup></a> Therefore, targeting CD276 is being explored as an immune-stimulatory strategy in cancer.<a href="#bib51" class="usa-link" aria-describedby="bib51"><sup>51</sup></a> CD200 is a checkpoint molecule that leads to suppression of secretion of proinflammatory cytokines, including interleukin-2 and I interferon-γ.<a href="#bib52" class="usa-link" aria-describedby="bib52"><sup>52</sup></a> Consistent with increased <em>CD200</em> expression in the SCLC samples we analyzed, CD200 protein was expressed in two other SCLC cohorts.<a href="#bib53" class="usa-link" aria-describedby="bib53"><sup>53</sup></a><sup>,</sup><a href="#bib54" class="usa-link" aria-describedby="bib54"><sup>54</sup></a> Furthermore, inhibiting the CD200 signaling axis has been reported to stimulate antigen-specific immune response against glioblastoma multiforme.<a href="#bib52" class="usa-link" aria-describedby="bib52"><sup>52</sup></a> Therefore, these results support further exploration of targeting CD276 or CD200 in preclinical SCLC models to determine whether inhibiting these checkpoint pathways may yield viable therapeutic strategies for advanced SCLC.</p>
<p id="p0185">As drug development efforts focus on programmed cell death protein 1/PD-L1 and other immune regulatory checkpoints, characterization of both the immune microenvironment and tumor heterogeneity will be critical to differentiate responders from nonresponders. It will also be important to define the relationship between tumor heterogeneity and neoantigen formation. For example, in NSCLC, cytotoxic tumor-infiltrating T cells preferentially develop against clonal neoantigens (derived from clonal or truncal mutations) in patients with durable clinical benefit to ICI.<a href="#bib55" class="usa-link" aria-describedby="bib55"><sup>55</sup></a> The high smoking-associated TMB of SCLC suggests that there may be a high number of clonal neoantigens serving as therapeutic targets. Therefore, a combination of autopsy and ctDNA samples will be critical resources to help characterize the prevalence of clonal neoantigens and optimize their detection from liquid biopsy. This will enable the development of vaccine or T cell-based therapeutic strategies in SCLC and other solid cancers.</p>
<p id="p0190">In summary, we have partnered with patients for rapid research autopsy to study relapsed SCLC and performed extensive analyses of clonal heterogeneity, subclonal architecture, and the immune microenvironment. Our results suggest a potential explanation for why SCLC, a cancer with high TMB and thus potential tumor neoantigens, exhibits lower than expected response rates to ICI compared with other solid tumors with similar median TMB. Future studies using single-cell sequencing strategies will shed light on unanswered questions, including which cell types are the source of <em>ARG2</em> expression and whether CD200/CD276 are coexpressed. Metabolome profiling could identify additional metabolic vulnerabilities in SCLC that may be cotargeted to enhance ICI response. Innovative immunotherapeutic approaches targeting alternate checkpoints, potentially combined with isoform-specific ARG inhibition, may ultimately result in more robust clinical activity against advanced SCLC.</p></section><section id="ack0010" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p id="p0200">Dr. Chen is supported by NCI K08CA241309, an American Society of Clinical Oncology Young Investigator Award, and a Pelotonia Postdoctoral Research Fellowship. Mr. Bonneville is supported by NIGMS T32GM068412 and a Pelotonia Graduate Research Fellowship. Dr. Paruchuri is supported by a Pelotonia Postdoctoral Research Fellowship. Dr. Krook is supported by NCATS TL1TR002735. Dr. Roychowdhury is supported by an American Cancer Society grant MRSG-12-194-01-TBG, the Prostate Cancer Foundation, NHGRI UM1HG006508, NCI UH2CA202971, NCI UH2CA216432, American Lung Association, and Pelotonia. The authors are grateful for technical advice and support for NextSeq sequencing from Dr. Dara Aisner in the Department of Pathology at the University of Colorado School of Medicine, Dr. Eric Haura and Dr. Theresa Boyle at Moffitt Cancer Center and Dr. Konstantin Shilo at The Ohio State University for critical reading of the manuscript, excellent administrative support from Jenny Badillo, the Genomics Shared Resource at The Ohio State University Comprehensive Cancer Center, the Ohio Supercomputer Center, community support from Pelotonia, and the patients and their families for their participation in cancer research. The results published here are in part based on data generated by The Cancer Genome Atlas Research Network: <a href="https://www.cancer.gov/tcga" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.cancer.gov/tcga</a>.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="d35e461"><p id="ntpara0010">Dr. Chen, Mr. Bonneville, and Dr. Paruchuri contributed equally to this work.</p></div>
<div class="fn p" id="d35e464"><p id="ntpara0015">Disclosure: Dr. Roychowdhury participated in the Advisory Board (Bayer, 2020) for Incyte Corporation (2017), AbbVie Inc. (2017), and QED Therapeutics (2018, 2019); received honoraria from IDT Integrated DNA Technologies (2017) and Illumina (2018); received consulting fees from QED Therapeutics (2018); and received travel reimbursement (less than $999 USD) from Incyte Corporation (2019). Dr. Chen received honoraria from QED Therapeutics (2019, 2020). The remaining authors declare no conflict of interest.</p></div>
<div class="fn p" id="d35e473"><p id="ntpara0020">Cite this article as: Chen HZ, Bonneville R, Paruchuri A, et al. Genomic and transcriptomic characterization of relapsed SCLC through rapid research autopsy. <em>JTO Clin Res Rep.</em> 2021;2:100164.</p></div>
<div class="fn p" id="appsec2"><p id="p0210">To access the supplementary material accompanying this article, visit the online version of the <em>JTO Clinical and Research Reports</em> at <a href="http://www.jtocrr.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.jtocrr.org</a> and at <a href="https://doi.org/10.1016/j.jtocrr.2021.100164" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.1016/j.jtocrr.2021.100164</a></p></div>
</div></section><section id="appsec1"><h2 class="pmc_sec_title">Supplementary Data</h2>
<section class="sm xbox font-sm" id="mmc1"><div class="caption p"><span>Supplemental Methods</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc1.pdf" data-ga-action="click_feat_suppl" class="usa-link">mmc1.pdf</a><sup> (252.9KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="mmc10"><div class="caption p"><span>FALCON Copy Number Variatiaon data</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc10.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc10.xlsx</a><sup> (538.8KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="mmc11"><div class="caption p"><span>Canopy Clonal Fractions</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc11.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc11.xlsx</a><sup> (23.8KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="mmc12"><div class="caption p"><span>Predicted Driver Mutations in Wnt Signaling</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc12.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc12.xlsx</a><sup> (25.9KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="mmc13"><div class="caption p"><span>Ordered Mutations, CNVs and Signatures by Phylogeny</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc13.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc13.xlsx</a><sup> (2.7MB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="mmc14"><div class="caption p"><span>ctDNA SNVs, indels and CNVs in Patient SCLC 5</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc14.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc14.xlsx</a><sup> (323.2KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="mmc15"><div class="caption p"><span>ssGSEA and ImSig SCLC</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc15.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc15.xlsx</a><sup> (98KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="mmc16"><div class="caption p"><span>T cell-inflamed GEP SCLC_NSCLC Gene TPM</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc16.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc16.xlsx</a><sup> (336.4KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="mmc17"><div class="caption p"><span>T cell-inflamed GEP Scores in SCLC</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc17.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc17.xlsx</a><sup> (190.5KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="mmc18"><div class="caption p"><span>Molecular Subtypes SCLC</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc18.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc18.xlsx</a><sup> (128.9KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="mmc2"><div class="caption p"><span>Supplementary Figures 1-8</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc2.pptx" data-ga-action="click_feat_suppl" class="usa-link">mmc2.pptx</a><sup> (5.2MB, pptx) </sup>
</div></div></section><section class="sm xbox font-sm" id="mmc3"><div class="caption p"><span>Next Generation Sequencing Summary</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc3.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc3.xlsx</a><sup> (34KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="mmc4"><div class="caption p"><span>Patient SCLC 1 Annotated Mutations by Sample</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc4.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc4.xlsx</a><sup> (4.9MB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="mmc5"><div class="caption p"><span>Patient SCLC 2 Annotated Mutations by Sample</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc5.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc5.xlsx</a><sup> (1.3MB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="mmc6"><div class="caption p"><span>Patient SCLC 3 Annotated Mutations by Sample</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc6.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc6.xlsx</a><sup> (3.8MB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="mmc7"><div class="caption p"><span>Patient SCLC 4 Annotated Mutations by Sample</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc7.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc7.xlsx</a><sup> (1.2MB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="mmc8"><div class="caption p"><span>Patient SCLC 5 Annotated Mutations by Sample</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc8.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc8.xlsx</a><sup> (2.7MB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="mmc9"><div class="caption p"><span>MuSiC Significantly Mutated Genes</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc9.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc9.xlsx</a><sup> (5.4MB, xlsx) </sup>
</div></div></section></section><section id="cebib0010" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="cebib0010_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="bib1">
<span class="label">1.</span><cite>Sabari J.K., Lok B.H., Laird J.H., Poirier J.T., Rudin C.M. Unravelling the biology of SCLC: implications for therapy. Nat Rev Clin Oncol. 2017;14:549–561. doi: 10.1038/nrclinonc.2017.71.</cite> [<a href="https://doi.org/10.1038/nrclinonc.2017.71" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5843484/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28534531/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Clin%20Oncol&amp;title=Unravelling%20the%20biology%20of%20SCLC:%20implications%20for%20therapy&amp;author=J.K.%20Sabari&amp;author=B.H.%20Lok&amp;author=J.H.%20Laird&amp;author=J.T.%20Poirier&amp;author=C.M.%20Rudin&amp;volume=14&amp;publication_year=2017&amp;pages=549-561&amp;pmid=28534531&amp;doi=10.1038/nrclinonc.2017.71&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib2">
<span class="label">2.</span><cite>Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34. doi: 10.3322/caac.21551.</cite> [<a href="https://doi.org/10.3322/caac.21551" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30620402/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CA%20Cancer%20J%20Clin&amp;title=Cancer%20statistics,%202019&amp;author=R.L.%20Siegel&amp;author=K.D.%20Miller&amp;author=A.%20Jemal&amp;volume=69&amp;publication_year=2019&amp;pages=7-34&amp;pmid=30620402&amp;doi=10.3322/caac.21551&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib3">
<span class="label">3.</span><cite>Horn L., Mansfield A.S., Szczęsna A. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer. N Engl J Med. 2018;379:2220–2229. doi: 10.1056/NEJMoa1809064.</cite> [<a href="https://doi.org/10.1056/NEJMoa1809064" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30280641/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%C2%A0Engl%20J%20Med&amp;title=First-line%20atezolizumab%20plus%20chemotherapy%20in%20extensive-stage%20small-cell%20lung%20cancer&amp;author=L.%20Horn&amp;author=A.S.%20Mansfield&amp;author=A.%20Szcz%C4%99sna&amp;volume=379&amp;publication_year=2018&amp;pages=2220-2229&amp;pmid=30280641&amp;doi=10.1056/NEJMoa1809064&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib4">
<span class="label">4.</span><cite>Paz-Ares L., Dvorkin M., Chen Y. Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (Caspian): a randomised, controlled, open-label, phase 3 trial. Lancet. 2019;394:1929–1939. doi: 10.1016/S0140-6736(19)32222-6.</cite> [<a href="https://doi.org/10.1016/S0140-6736(19)32222-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31590988/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Durvalumab%20plus%20platinum-etoposide%20versus%20platinum-etoposide%20in%20first-line%20treatment%20of%20extensive-stage%20small-cell%20lung%20cancer%20(Caspian):%20a%20randomised,%20controlled,%20open-label,%20phase%203%20trial&amp;author=L.%20Paz-Ares&amp;author=M.%20Dvorkin&amp;author=Y.%20Chen&amp;volume=394&amp;publication_year=2019&amp;pages=1929-1939&amp;pmid=31590988&amp;doi=10.1016/S0140-6736(19)32222-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib5">
<span class="label">5.</span><cite>von Pawel J., Schiller J.H., Shepherd F.A. Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer. J Clin Oncol. 1999;17 doi: 10.1200/JCO.1999.17.2.658. 658–658.</cite> [<a href="https://doi.org/10.1200/JCO.1999.17.2.658" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10080612/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%C2%A0Clin%20Oncol&amp;title=Topotecan%20versus%20cyclophosphamide,%20doxorubicin,%20and%20vincristine%20for%20the%20treatment%20of%20recurrent%20small-cell%20lung%20cancer&amp;author=J.%20von%20Pawel&amp;author=J.H.%20Schiller&amp;author=F.A.%20Shepherd&amp;volume=17&amp;publication_year=1999&amp;pmid=10080612&amp;doi=10.1200/JCO.1999.17.2.658&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib6">
<span class="label">6.</span><cite>Trigo J., Subbiah V., Besse B. Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial. Lancet Oncol. 2020;21:645–654. doi: 10.1016/S1470-2045(20)30068-1.</cite> [<a href="https://doi.org/10.1016/S1470-2045(20)30068-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32224306/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol&amp;title=Lurbinectedin%20as%20second-line%20treatment%20for%20patients%20with%20small-cell%20lung%20cancer:%20a%20single-arm,%20open-label,%20phase%202%20basket%20trial&amp;author=J.%20Trigo&amp;author=V.%20Subbiah&amp;author=B.%20Besse&amp;volume=21&amp;publication_year=2020&amp;pages=645-654&amp;pmid=32224306&amp;doi=10.1016/S1470-2045(20)30068-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib7">
<span class="label">7.</span><cite>George J., Lim J.S., Jang S.J. Comprehensive genomic profiles of small cell lung cancer. Nature. 2015;524:47–53. doi: 10.1038/nature14664.</cite> [<a href="https://doi.org/10.1038/nature14664" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4861069/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26168399/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Comprehensive%20genomic%20profiles%20of%20small%20cell%20lung%20cancer&amp;author=J.%20George&amp;author=J.S.%20Lim&amp;author=S.J.%20Jang&amp;volume=524&amp;publication_year=2015&amp;pages=47-53&amp;pmid=26168399&amp;doi=10.1038/nature14664&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib8">
<span class="label">8.</span><cite>Rudin C.M., Durinck S., Stawiski E.W. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat Genet. 2012;44:1111–1116. doi: 10.1038/ng.2405.</cite> [<a href="https://doi.org/10.1038/ng.2405" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3557461/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22941189/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Genet&amp;title=Comprehensive%20genomic%20analysis%20identifies%20SOX2%20as%20a%20frequently%20amplified%20gene%20in%20small-cell%20lung%20cancer&amp;author=C.M.%20Rudin&amp;author=S.%20Durinck&amp;author=E.W.%20Stawiski&amp;volume=44&amp;publication_year=2012&amp;pages=1111-1116&amp;pmid=22941189&amp;doi=10.1038/ng.2405&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib9">
<span class="label">9.</span><cite>Peifer M., Fernández-Cuesta L., Sos M.L. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet. 2012;44:1104–1110. doi: 10.1038/ng.2396.</cite> [<a href="https://doi.org/10.1038/ng.2396" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4915822/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22941188/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Genet&amp;title=Integrative%20genome%20analyses%20identify%20key%20somatic%20driver%20mutations%20of%20small-cell%20lung%20cancer&amp;author=M.%20Peifer&amp;author=L.%20Fern%C3%A1ndez-Cuesta&amp;author=M.L.%20Sos&amp;volume=44&amp;publication_year=2012&amp;pages=1104-1110&amp;pmid=22941188&amp;doi=10.1038/ng.2396&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib10">
<span class="label">10.</span><cite>Rudin C.M., Poirier J.T., Byers L.A. Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data. Nat Rev Cancer. 2019;19:289–297. doi: 10.1038/s41568-019-0133-9.</cite> [<a href="https://doi.org/10.1038/s41568-019-0133-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6538259/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30926931/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Cancer&amp;title=Molecular%20subtypes%20of%20small%20cell%20lung%20cancer:%20a%20synthesis%20of%20human%20and%20mouse%20model%20data&amp;author=C.M.%20Rudin&amp;author=J.T.%20Poirier&amp;author=L.A.%20Byers&amp;volume=19&amp;publication_year=2019&amp;pages=289-297&amp;pmid=30926931&amp;doi=10.1038/s41568-019-0133-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib11">
<span class="label">11.</span><cite>Baine M.K., Hsieh M.S., Lai W.V. SCLC subtypes defined by ASCL1, NEUROD1, POU2F3 and YAP1: a comprehensive immunohistochemical and histopathologic characterization. J Thorac Oncol. 2020;15:1823–1835. doi: 10.1016/j.jtho.2020.09.009.</cite> [<a href="https://doi.org/10.1016/j.jtho.2020.09.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8362797/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33011388/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%C2%A0Thorac%20Oncol&amp;title=SCLC%20subtypes%20defined%20by%20ASCL1,%20NEUROD1,%20POU2F3%20and%20YAP1:%20a%20comprehensive%20immunohistochemical%20and%20histopathologic%20characterization&amp;author=M.K.%20Baine&amp;author=M.S.%20Hsieh&amp;author=W.V.%20Lai&amp;volume=15&amp;publication_year=2020&amp;pages=1823-1835&amp;pmid=33011388&amp;doi=10.1016/j.jtho.2020.09.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib12">
<span class="label">12.</span><cite>Gay C.M., Stewart C.A., Park E.M. Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities. Cancer Cell. 2021;39:346–360. doi: 10.1016/j.ccell.2020.12.014. e7.</cite> [<a href="https://doi.org/10.1016/j.ccell.2020.12.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8143037/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33482121/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Cell&amp;title=Patterns%20of%20transcription%20factor%20programs%20and%20immune%20pathway%20activation%20define%20four%20major%20subtypes%20of%20SCLC%20with%20distinct%20therapeutic%20vulnerabilities&amp;author=C.M.%20Gay&amp;author=C.A.%20Stewart&amp;author=E.M.%20Park&amp;volume=39&amp;publication_year=2021&amp;pages=346-360&amp;pmid=33482121&amp;doi=10.1016/j.ccell.2020.12.014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib13">
<span class="label">13.</span><cite>Gardner E.E., Lok B.H., Schneeberger V.E. Chemosensitive relapse in small cell lung cancer proceeds through an EZH2-SLFN11 axis. Cancer Cell. 2017;31:286–299. doi: 10.1016/j.ccell.2017.01.006.</cite> [<a href="https://doi.org/10.1016/j.ccell.2017.01.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5313262/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28196596/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Cell&amp;title=Chemosensitive%20relapse%20in%20small%20cell%20lung%20cancer%20proceeds%20through%20an%20EZH2-SLFN11%20axis&amp;author=E.E.%20Gardner&amp;author=B.H.%20Lok&amp;author=V.E.%20Schneeberger&amp;volume=31&amp;publication_year=2017&amp;pages=286-299&amp;pmid=28196596&amp;doi=10.1016/j.ccell.2017.01.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib14">
<span class="label">14.</span><cite>Wagner A.H., Devarakonda S., Skidmore Z.L. Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer. Nat Commun. 2018;9:3787. doi: 10.1038/s41467-018-06162-9.</cite> [<a href="https://doi.org/10.1038/s41467-018-06162-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6141466/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30224629/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=Recurrent%20WNT%20pathway%20alterations%20are%20frequent%20in%20relapsed%20small%20cell%20lung%20cancer&amp;author=A.H.%20Wagner&amp;author=S.%20Devarakonda&amp;author=Z.L.%20Skidmore&amp;volume=9&amp;publication_year=2018&amp;pages=3787&amp;pmid=30224629&amp;doi=10.1038/s41467-018-06162-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib15">
<span class="label">15.</span><cite>Weiss G.J., Byron S.A., Aldrich J. A prospective pilot study of genome-wide exome and transcriptome profiling in patients with small cell lung cancer progressing after first-line therapy. PLoS One. 2017;12 doi: 10.1371/journal.pone.0179170.</cite> [<a href="https://doi.org/10.1371/journal.pone.0179170" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5460863/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28586388/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=A%C2%A0prospective%20pilot%20study%20of%20genome-wide%20exome%20and%20transcriptome%20profiling%20in%20patients%20with%20small%20cell%20lung%20cancer%20progressing%20after%20first-line%20therapy&amp;author=G.J.%20Weiss&amp;author=S.A.%20Byron&amp;author=J.%20Aldrich&amp;volume=12&amp;publication_year=2017&amp;pmid=28586388&amp;doi=10.1371/journal.pone.0179170&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib16">
<span class="label">16.</span><cite>Stewart C.A., Gay C.M., Xi Y. Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer. Nat Cancer. 2020;1:423–436. doi: 10.1038/s43018-019-0020-z.</cite> [<a href="https://doi.org/10.1038/s43018-019-0020-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7842382/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33521652/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Cancer&amp;title=Single-cell%20analyses%20reveal%20increased%20intratumoral%20heterogeneity%20after%20the%20onset%20of%20therapy%20resistance%20in%20small-cell%20lung%20cancer&amp;author=C.A.%20Stewart&amp;author=C.M.%20Gay&amp;author=Y.%20Xi&amp;volume=1&amp;publication_year=2020&amp;pages=423-436&amp;pmid=33521652&amp;doi=10.1038/s43018-019-0020-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib17">
<span class="label">17.</span><cite>Krook M.A., Chen H.Z., Bonneville R., Allenby P., Roychowdhury S. Rapid research autopsy: piecing the puzzle of tumor heterogeneity. Trends Cancer. 2019;5:1–5. doi: 10.1016/j.trecan.2018.11.004.</cite> [<a href="https://doi.org/10.1016/j.trecan.2018.11.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30616752/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20Cancer&amp;title=Rapid%20research%20autopsy:%20piecing%20the%20puzzle%20of%20tumor%20heterogeneity&amp;author=M.A.%20Krook&amp;author=H.Z.%20Chen&amp;author=R.%20Bonneville&amp;author=P.%20Allenby&amp;author=S.%20Roychowdhury&amp;volume=5&amp;publication_year=2019&amp;pages=1-5&amp;pmid=30616752&amp;doi=10.1016/j.trecan.2018.11.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib18">
<span class="label">18.</span><cite>Krook M.A., Bonneville R., Chen H.Z. Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma through rapid research autopsy. Cold Spring Harb Mol Case Stud. 2019;5:1–5. doi: 10.1101/mcs.a004002.</cite> [<a href="https://doi.org/10.1101/mcs.a004002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6672025/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31371345/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cold%20Spring%20Harb%20Mol%20Case%20Stud&amp;title=Tumor%20heterogeneity%20and%20acquired%20drug%20resistance%20in%20FGFR2-fusion-positive%20cholangiocarcinoma%20through%20rapid%20research%20autopsy&amp;author=M.A.%20Krook&amp;author=R.%20Bonneville&amp;author=H.Z.%20Chen&amp;volume=5&amp;publication_year=2019&amp;pages=1-5&amp;pmid=31371345&amp;doi=10.1101/mcs.a004002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib19">
<span class="label">19.</span><cite>Reeser J.W., Martin D., Miya J. Validation of a targeted RNA sequencing assay for kinase fusion detection in solid tumors. J Mol Diagn. 2017;19:682–696. doi: 10.1016/j.jmoldx.2017.05.006.</cite> [<a href="https://doi.org/10.1016/j.jmoldx.2017.05.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5975628/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28802831/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%C2%A0Mol%20Diagn&amp;title=Validation%20of%20a%20targeted%20RNA%20sequencing%20assay%20for%20kinase%20fusion%20detection%20in%20solid%20tumors&amp;author=J.W.%20Reeser&amp;author=D.%20Martin&amp;author=J.%20Miya&amp;volume=19&amp;publication_year=2017&amp;pages=682-696&amp;pmid=28802831&amp;doi=10.1016/j.jmoldx.2017.05.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib20">
<span class="label">20.</span><cite>Griffith M., Miller C.A., Griffith O.L. Optimizing cancer genome sequencing and analysis. Cell Syst. 2015;1:210–223. doi: 10.1016/j.cels.2015.08.015.</cite> [<a href="https://doi.org/10.1016/j.cels.2015.08.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4669575/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26645048/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Syst&amp;title=Optimizing%20cancer%20genome%20sequencing%20and%20analysis&amp;author=M.%20Griffith&amp;author=C.A.%20Miller&amp;author=O.L.%20Griffith&amp;volume=1&amp;publication_year=2015&amp;pages=210-223&amp;pmid=26645048&amp;doi=10.1016/j.cels.2015.08.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib21">
<span class="label">21.</span><cite>Li H., Durbin R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics. 2009;25:1754–1760. doi: 10.1093/bioinformatics/btp324.</cite> [<a href="https://doi.org/10.1093/bioinformatics/btp324" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2705234/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19451168/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=Fast%20and%20accurate%20short%20read%20alignment%20with%20Burrows%E2%80%93Wheeler%20transform&amp;author=H.%20Li&amp;author=R.%20Durbin&amp;volume=25&amp;publication_year=2009&amp;pages=1754-1760&amp;pmid=19451168&amp;doi=10.1093/bioinformatics/btp324&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib22">
<span class="label">22.</span><cite>McKenna A., Hanna M., Banks E. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297–1303. doi: 10.1101/gr.107524.110.</cite> [<a href="https://doi.org/10.1101/gr.107524.110" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2928508/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20644199/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome%20Res&amp;title=The%20Genome%20Analysis%20Toolkit:%20a%20MapReduce%20framework%20for%20analyzing%20next-generation%20DNA%20sequencing%20data&amp;author=A.%20McKenna&amp;author=M.%20Hanna&amp;author=E.%20Banks&amp;volume=20&amp;publication_year=2010&amp;pages=1297-1303&amp;pmid=20644199&amp;doi=10.1101/gr.107524.110&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib23">
<span class="label">23.</span><cite>Koboldt D.C., Zhang Q., Larson D.E. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 2012;22:568–576. doi: 10.1101/gr.129684.111.</cite> [<a href="https://doi.org/10.1101/gr.129684.111" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3290792/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22300766/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome%20Res&amp;title=VarScan%202:%20somatic%20mutation%20and%20copy%20number%20alteration%20discovery%20in%20cancer%20by%20exome%20sequencing&amp;author=D.C.%20Koboldt&amp;author=Q.%20Zhang&amp;author=D.E.%20Larson&amp;volume=22&amp;publication_year=2012&amp;pages=568-576&amp;pmid=22300766&amp;doi=10.1101/gr.129684.111&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib24">
<span class="label">24.</span><cite>Chen H., Bell J.M., Zavala N.A., Ji H.P., Zhang N.R. Allele-specific copy number profiling by next-generation DNA sequencing. Nucleic Acids Res. 2015;43:e23. doi: 10.1093/nar/gku1252.</cite> [<a href="https://doi.org/10.1093/nar/gku1252" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4344483/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25477383/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res&amp;title=Allele-specific%20copy%20number%20profiling%20by%20next-generation%20DNA%20sequencing&amp;author=H.%20Chen&amp;author=J.M.%20Bell&amp;author=N.A.%20Zavala&amp;author=H.P.%20Ji&amp;author=N.R.%20Zhang&amp;volume=43&amp;publication_year=2015&amp;pages=e23&amp;pmid=25477383&amp;doi=10.1093/nar/gku1252&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib25">
<span class="label">25.</span><cite>Jiang Y., Qiu Y., Minn A.J., Zhang N.R. Assessing intratumor heterogeneity and tracking longitudinal and spatial clonal evolutionary history by next-generation sequencing. Proc Natl Acad Sci U S A. 2016;113:E5528–E5537. doi: 10.1073/pnas.1522203113.</cite> [<a href="https://doi.org/10.1073/pnas.1522203113" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5027458/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27573852/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&amp;title=Assessing%20intratumor%20heterogeneity%20and%20tracking%20longitudinal%20and%20spatial%20clonal%20evolutionary%20history%20by%20next-generation%20sequencing&amp;author=Y.%20Jiang&amp;author=Y.%20Qiu&amp;author=A.J.%20Minn&amp;author=N.R.%20Zhang&amp;volume=113&amp;publication_year=2016&amp;pages=E5528-E5537&amp;pmid=27573852&amp;doi=10.1073/pnas.1522203113&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib26">
<span class="label">26.</span><cite>Rosenthal R., McGranahan N., Herrero J., Taylor B.S., Swanton C. DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution. Genome Biol. 2016;17:31. doi: 10.1186/s13059-016-0893-4.</cite> [<a href="https://doi.org/10.1186/s13059-016-0893-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4762164/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26899170/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome%20Biol&amp;title=DeconstructSigs:%20delineating%20mutational%20processes%20in%20single%20tumors%20distinguishes%20DNA%20repair%20deficiencies%20and%20patterns%20of%20carcinoma%20evolution&amp;author=R.%20Rosenthal&amp;author=N.%20McGranahan&amp;author=J.%20Herrero&amp;author=B.S.%20Taylor&amp;author=C.%20Swanton&amp;volume=17&amp;publication_year=2016&amp;pages=31&amp;pmid=26899170&amp;doi=10.1186/s13059-016-0893-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib27">
<span class="label">27.</span><cite>Dees N.D., Zhang Q., Kandoth C. MuSiC: identifying mutational significance in cancer genomes. Genome Res. 2012;22:1589–1598. doi: 10.1101/gr.134635.111.</cite> [<a href="https://doi.org/10.1101/gr.134635.111" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3409272/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22759861/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome%20Res&amp;title=MuSiC:%20identifying%20mutational%20significance%20in%20cancer%20genomes&amp;author=N.D.%20Dees&amp;author=Q.%20Zhang&amp;author=C.%20Kandoth&amp;volume=22&amp;publication_year=2012&amp;pages=1589-1598&amp;pmid=22759861&amp;doi=10.1101/gr.134635.111&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib28">
<span class="label">28.</span><cite>Carter H., Chen S., Isik L. Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. Cancer Res. 2009;69:6660–6667. doi: 10.1158/0008-5472.CAN-09-1133.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-09-1133" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2763410/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19654296/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&amp;title=Cancer-specific%20high-throughput%20annotation%20of%20somatic%20mutations:%20computational%20prediction%20of%20driver%20missense%20mutations&amp;author=H.%20Carter&amp;author=S.%20Chen&amp;author=L.%20Isik&amp;volume=69&amp;publication_year=2009&amp;pages=6660-6667&amp;pmid=19654296&amp;doi=10.1158/0008-5472.CAN-09-1133&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib29">
<span class="label">29.</span><cite>Kim D., Paggi J.M., Park C., Bennett C., Salzberg S.L. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37:907–915. doi: 10.1038/s41587-019-0201-4.</cite> [<a href="https://doi.org/10.1038/s41587-019-0201-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7605509/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31375807/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Biotechnol&amp;title=Graph-based%C2%A0genome%20alignment%20and%20genotyping%20with%20HISAT2%20and%20HISAT-genotype&amp;author=D.%20Kim&amp;author=J.M.%20Paggi&amp;author=C.%20Park&amp;author=C.%20Bennett&amp;author=S.L.%20Salzberg&amp;volume=37&amp;publication_year=2019&amp;pages=907-915&amp;pmid=31375807&amp;doi=10.1038/s41587-019-0201-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib30">
<span class="label">30.</span><cite>Kovaka S., Zimin A.V., Pertea G.M., Razaghi R., Salzberg S.L., Pertea M. Transcriptome assembly from long-read RNA-seq alignments with StringTie2. Genome Biol. 2019;20:278. doi: 10.1186/s13059-019-1910-1.</cite> [<a href="https://doi.org/10.1186/s13059-019-1910-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6912988/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31842956/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome%20Biol&amp;title=Transcriptome%20assembly%20from%20long-read%20RNA-seq%20alignments%20with%20StringTie2&amp;author=S.%20Kovaka&amp;author=A.V.%20Zimin&amp;author=G.M.%20Pertea&amp;author=R.%20Razaghi&amp;author=S.L.%20Salzberg&amp;volume=20&amp;publication_year=2019&amp;pages=278&amp;pmid=31842956&amp;doi=10.1186/s13059-019-1910-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib31">
<span class="label">31.</span><cite>Barbie D.A., Tamayo P., Boehm J.S. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature. 2009;462:108–112. doi: 10.1038/nature08460.</cite> [<a href="https://doi.org/10.1038/nature08460" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2783335/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19847166/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Systematic%20RNA%20interference%20reveals%20that%20oncogenic%20KRAS-driven%20cancers%20require%20TBK1&amp;author=D.A.%20Barbie&amp;author=P.%20Tamayo&amp;author=J.S.%20Boehm&amp;volume=462&amp;publication_year=2009&amp;pages=108-112&amp;pmid=19847166&amp;doi=10.1038/nature08460&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib32">
<span class="label">32.</span><cite>Nirmal A.J., Regan T., Shih B.B., Hume D.A., Sims A.H., Freeman T.C. Immune cell gene signatures for profiling the microenvironment of solid tumors. Cancer Immunol Res. 2018;6:1388–1400. doi: 10.1158/2326-6066.CIR-18-0342.</cite> [<a href="https://doi.org/10.1158/2326-6066.CIR-18-0342" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30266715/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Immunol%20Res&amp;title=Immune%20cell%20gene%20signatures%20for%20profiling%20the%20microenvironment%20of%20solid%20tumors&amp;author=A.J.%20Nirmal&amp;author=T.%20Regan&amp;author=B.B.%20Shih&amp;author=D.A.%20Hume&amp;author=A.H.%20Sims&amp;volume=6&amp;publication_year=2018&amp;pages=1388-1400&amp;pmid=30266715&amp;doi=10.1158/2326-6066.CIR-18-0342&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib33">
<span class="label">33.</span><cite>Fagerberg L., Hallström B.M., Oksvold P. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics. 2014;13:397–406. doi: 10.1074/mcp.M113.035600.</cite> [<a href="https://doi.org/10.1074/mcp.M113.035600" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3916642/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24309898/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cell%20Proteomics&amp;title=Analysis%20of%20the%20human%20tissue-specific%20expression%20by%20genome-wide%20integration%20of%20transcriptomics%20and%20antibody-based%20proteomics&amp;author=L.%20Fagerberg&amp;author=B.M.%20Hallstr%C3%B6m&amp;author=P.%20Oksvold&amp;volume=13&amp;publication_year=2014&amp;pages=397-406&amp;pmid=24309898&amp;doi=10.1074/mcp.M113.035600&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib34">
<span class="label">34.</span><cite>Best S.A., Hess J.B., Souza-Fonseca-Guimaraes F. Harnessing natural killer immunity in metastatic SCLC. J Thorac Oncol. 2020;15:1507–1521. doi: 10.1016/j.jtho.2020.05.008.</cite> [<a href="https://doi.org/10.1016/j.jtho.2020.05.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32470639/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%C2%A0Thorac%20Oncol&amp;title=Harnessing%20natural%20killer%20immunity%20in%20metastatic%20SCLC&amp;author=S.A.%20Best&amp;author=J.B.%20Hess&amp;author=F.%20Souza-Fonseca-Guimaraes&amp;volume=15&amp;publication_year=2020&amp;pages=1507-1521&amp;pmid=32470639&amp;doi=10.1016/j.jtho.2020.05.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib35">
<span class="label">35.</span><cite>Cristescu R., Mogg R., Ayers M. Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy. Science. 2018;362:eaar3593. doi: 10.1126/science.aar3593.</cite> [<a href="https://doi.org/10.1126/science.aar3593" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6718162/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30309915/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Pan-tumor%20genomic%20biomarkers%20for%20PD-1%20checkpoint%20blockade%E2%80%93based%20immunotherapy&amp;author=R.%20Cristescu&amp;author=R.%20Mogg&amp;author=M.%20Ayers&amp;volume=362&amp;publication_year=2018&amp;pages=eaar3593&amp;pmid=30309915&amp;doi=10.1126/science.aar3593&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib36">
<span class="label">36.</span><cite>Cerami E., Gao J., Dogrusoz U. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401–404. doi: 10.1158/2159-8290.CD-12-0095.</cite> [<a href="https://doi.org/10.1158/2159-8290.CD-12-0095" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3956037/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22588877/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Discov&amp;title=The%20cBio%20cancer%20genomics%20portal:%20an%20open%20platform%20for%20exploring%20multidimensional%20cancer%20genomics%20data&amp;author=E.%20Cerami&amp;author=J.%20Gao&amp;author=U.%20Dogrusoz&amp;volume=2&amp;publication_year=2012&amp;pages=401-404&amp;pmid=22588877&amp;doi=10.1158/2159-8290.CD-12-0095&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib37">
<span class="label">37.</span><cite>Gao J., Aksoy B.A., Dogrusoz U. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1. doi: 10.1126/scisignal.2004088.</cite> [<a href="https://doi.org/10.1126/scisignal.2004088" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4160307/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23550210/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Signal&amp;title=Integrative%20analysis%20of%20complex%20cancer%20genomics%20and%20clinical%20profiles%20using%20the%20cBioPortal&amp;author=J.%20Gao&amp;author=B.A.%20Aksoy&amp;author=U.%20Dogrusoz&amp;volume=6&amp;publication_year=2013&amp;pages=pl1&amp;pmid=23550210&amp;doi=10.1126/scisignal.2004088&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib38">
<span class="label">38.</span><cite>Forbes S.A., Beare D., Boutselakis H. COSMIC: somatic cancer genetics at high-resolution. Nucleic Acids Res. 2016;45:D777–D783. doi: 10.1093/nar/gkw1121.</cite> [<a href="https://doi.org/10.1093/nar/gkw1121" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5210583/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27899578/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res&amp;title=COSMIC:%20somatic%20cancer%20genetics%20at%20high-resolution&amp;author=S.A.%20Forbes&amp;author=D.%20Beare&amp;author=H.%20Boutselakis&amp;volume=45&amp;publication_year=2016&amp;pages=D777-D783&amp;pmid=27899578&amp;doi=10.1093/nar/gkw1121&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib39">
<span class="label">39.</span><cite>Ayers M., Lunceford J., Nebozhyn M. IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade. J Clin Invest. 2017;127:2930–2940. doi: 10.1172/JCI91190.</cite> [<a href="https://doi.org/10.1172/JCI91190" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5531419/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28650338/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%C2%A0Clin%20Invest&amp;title=IFN-%CE%B3-related%20mRNA%20profile%20predicts%20clinical%20response%20to%20PD-1%20blockade&amp;author=M.%20Ayers&amp;author=J.%20Lunceford&amp;author=M.%20Nebozhyn&amp;volume=127&amp;publication_year=2017&amp;pages=2930-2940&amp;pmid=28650338&amp;doi=10.1172/JCI91190&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib40">
<span class="label">40.</span><cite>Iams W.T., Porter J., Horn L. Immunotherapeutic approaches for small-cell lung cancer. Nat Rev Clin Oncol. 2020;17:300–312. doi: 10.1038/s41571-019-0316-z.</cite> [<a href="https://doi.org/10.1038/s41571-019-0316-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7212527/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32055013/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Clin%20Oncol&amp;title=Immunotherapeutic%20approaches%20for%20small-cell%20lung%20cancer&amp;author=W.T.%20Iams&amp;author=J.%20Porter&amp;author=L.%20Horn&amp;volume=17&amp;publication_year=2020&amp;pages=300-312&amp;pmid=32055013&amp;doi=10.1038/s41571-019-0316-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib41">
<span class="label">41.</span><cite>O’Sullivan D., Sanin D.E., Pearce E.J., Pearce E.L. Metabolic interventions in the immune response to cancer. Nat Rev Immunol. 2019;19:324–335. doi: 10.1038/s41577-019-0140-9.</cite> [<a href="https://doi.org/10.1038/s41577-019-0140-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30820043/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Immunol&amp;title=Metabolic%20interventions%20in%20the%20immune%20response%20to%20cancer&amp;author=D.%20O%E2%80%99Sullivan&amp;author=D.E.%20Sanin&amp;author=E.J.%20Pearce&amp;author=E.L.%20Pearce&amp;volume=19&amp;publication_year=2019&amp;pages=324-335&amp;pmid=30820043&amp;doi=10.1038/s41577-019-0140-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib42">
<span class="label">42.</span><cite>Wang D., Saga Y., Mizukami H. Indoleamine-2,3-dioxygenase, an immunosuppressive enzyme that inhibits natural killer cell function, as a useful target for ovarian cancer therapy. Int J Oncol. 2012;40:929–934. doi: 10.3892/ijo.2011.1295.</cite> [<a href="https://doi.org/10.3892/ijo.2011.1295" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3584823/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22179492/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Oncol&amp;title=Indoleamine-2,3-dioxygenase,%20an%20immunosuppressive%20enzyme%20that%20inhibits%20natural%20killer%20cell%20function,%20as%20a%20useful%20target%20for%20ovarian%20cancer%20therapy&amp;author=D.%20Wang&amp;author=Y.%20Saga&amp;author=H.%20Mizukami&amp;volume=40&amp;publication_year=2012&amp;pages=929-934&amp;pmid=22179492&amp;doi=10.3892/ijo.2011.1295&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib43">
<span class="label">43.</span><cite>Grzywa T.M., Sosnowska A., Matryba P. Myeloid cell-derived arginase in cancer immune response. Front Immunol. 2020;11:938. doi: 10.3389/fimmu.2020.00938.</cite> [<a href="https://doi.org/10.3389/fimmu.2020.00938" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7242730/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32499785/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Immunol&amp;title=Myeloid%20cell-derived%20arginase%20in%20cancer%20immune%20response&amp;author=T.M.%20Grzywa&amp;author=A.%20Sosnowska&amp;author=P.%20Matryba&amp;volume=11&amp;publication_year=2020&amp;pages=938&amp;pmid=32499785&amp;doi=10.3389/fimmu.2020.00938&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib44">
<span class="label">44.</span><cite>Beer A.G., Zenzmaier C., Schreinlechner M. Expression of a recombinant full-length LRP1B receptor in human non-small cell lung cancer cells confirms the postulated growth-suppressing function of this large LDL receptor family member. Oncotarget. 2016;7:68721–68733. doi: 10.18632/oncotarget.11897.</cite> [<a href="https://doi.org/10.18632/oncotarget.11897" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5356585/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27626682/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Expression%20of%20a%20recombinant%20full-length%20LRP1B%20receptor%20in%20human%20non-small%20cell%20lung%20cancer%20cells%20confirms%20the%20postulated%20growth-suppressing%20function%20of%20this%20large%20LDL%20receptor%20family%20member&amp;author=A.G.%20Beer&amp;author=C.%20Zenzmaier&amp;author=M.%20Schreinlechner&amp;volume=7&amp;publication_year=2016&amp;pages=68721-68733&amp;pmid=27626682&amp;doi=10.18632/oncotarget.11897&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib45">
<span class="label">45.</span><cite>Prazeres H., Torres J., Rodrigues F. Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells. Oncogene. 2017;36:146. doi: 10.1038/onc.2016.143.</cite> [<a href="https://doi.org/10.1038/onc.2016.143" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27499094/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Chromosomal,%20epigenetic%20and%20microRNA-mediated%20inactivation%20of%20LRP1B,%20a%20modulator%20of%20the%20extracellular%20environment%20of%20thyroid%20cancer%20cells&amp;author=H.%20Prazeres&amp;author=J.%20Torres&amp;author=F.%20Rodrigues&amp;volume=36&amp;publication_year=2017&amp;pages=146&amp;pmid=27499094&amp;doi=10.1038/onc.2016.143&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib46">
<span class="label">46.</span><cite>Wang Z., Sun P., Gao C. Down-regulation of LRP1B in colon cancer promoted the growth and migration of cancer cells. Exp Cell Res. 2017;357:1–8. doi: 10.1016/j.yexcr.2017.04.010.</cite> [<a href="https://doi.org/10.1016/j.yexcr.2017.04.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28408316/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Exp%20Cell%20Res&amp;title=Down-regulation%20of%20LRP1B%20in%20colon%20cancer%20promoted%20the%20growth%20and%20migration%20of%20cancer%20cells&amp;author=Z.%20Wang&amp;author=P.%20Sun&amp;author=C.%20Gao&amp;volume=357&amp;publication_year=2017&amp;pages=1-8&amp;pmid=28408316&amp;doi=10.1016/j.yexcr.2017.04.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib47">
<span class="label">47.</span><cite>Nong J., Gong Y., Guan Y. Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer. Nat Commun. 2018;9:3114. doi: 10.1038/s41467-018-05327-w.</cite> [<a href="https://doi.org/10.1038/s41467-018-05327-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6079068/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30082701/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=Circulating%20tumor%20DNA%20analysis%20depicts%20subclonal%20architecture%20and%20genomic%20evolution%20of%20small%20cell%20lung%20cancer&amp;author=J.%20Nong&amp;author=Y.%20Gong&amp;author=Y.%20Guan&amp;volume=9&amp;publication_year=2018&amp;pages=3114&amp;pmid=30082701&amp;doi=10.1038/s41467-018-05327-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib48">
<span class="label">48.</span><cite>Iwakawa R., Takenaka M., Kohno T. Genome-wide identification of genes with amplification and/or fusion in small cell lung cancer. Genes Chromosomes Cancer. 2013;52:802–816. doi: 10.1002/gcc.22076.</cite> [<a href="https://doi.org/10.1002/gcc.22076" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3806277/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23716474/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genes%20Chromosomes%20Cancer&amp;title=Genome-wide%20identification%20of%20genes%20with%20amplification%20and/or%20fusion%20in%20small%20cell%20lung%20cancer&amp;author=R.%20Iwakawa&amp;author=M.%20Takenaka&amp;author=T.%20Kohno&amp;volume=52&amp;publication_year=2013&amp;pages=802-816&amp;pmid=23716474&amp;doi=10.1002/gcc.22076&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib49">
<span class="label">49.</span><cite>Carvajal-Hausdorf D., Altan M., Velcheti V. Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC) J Immunother Cancer. 2019;7:65. doi: 10.1186/s40425-019-0540-1.</cite> [<a href="https://doi.org/10.1186/s40425-019-0540-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6408760/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30850021/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%C2%A0Immunother%20Cancer&amp;title=Expression%20and%20clinical%20significance%20of%20PD-L1,%20B7-H3,%20B7-H4%20and%20TILs%20in%20human%20small%20cell%20lung%20Cancer%20(SCLC)&amp;author=D.%20Carvajal-Hausdorf&amp;author=M.%20Altan&amp;author=V.%20Velcheti&amp;volume=7&amp;publication_year=2019&amp;pages=65&amp;pmid=30850021&amp;doi=10.1186/s40425-019-0540-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib50">
<span class="label">50.</span><cite>Dong P., Xiong Y., Yue J., Hanley S.J.B., Watari H. B7H3 as a promoter of metastasis and promising therapeutic target. Front Oncol. 2018;8:264. doi: 10.3389/fonc.2018.00264.</cite> [<a href="https://doi.org/10.3389/fonc.2018.00264" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6043641/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30035102/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Oncol&amp;title=B7H3%20as%20a%20promoter%20of%20metastasis%20and%20promising%20therapeutic%20target&amp;author=P.%20Dong&amp;author=Y.%20Xiong&amp;author=J.%20Yue&amp;author=S.J.B.%20Hanley&amp;author=H.%20Watari&amp;volume=8&amp;publication_year=2018&amp;pages=264&amp;pmid=30035102&amp;doi=10.3389/fonc.2018.00264&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib51">
<span class="label">51.</span><cite>Picarda E., Ohaegbulam K.C., Zang X. Molecular pathways: targeting B7-H3 (CD276) for human cancer immunotherapy. Clin Cancer Res Off J Am Assoc Cancer Res. 2016;22:3425–3431. doi: 10.1158/1078-0432.CCR-15-2428.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-15-2428" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4947428/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27208063/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res%20Off%20J%20Am%20Assoc%20Cancer%20Res&amp;title=Molecular%20pathways:%20targeting%20B7-H3%20(CD276)%20for%20human%20cancer%20immunotherapy&amp;author=E.%20Picarda&amp;author=K.C.%20Ohaegbulam&amp;author=X.%20Zang&amp;volume=22&amp;publication_year=2016&amp;pages=3425-3431&amp;pmid=27208063&amp;doi=10.1158/1078-0432.CCR-15-2428&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib52">
<span class="label">52.</span><cite>Xiong Z., Ampudia Mesias E., Pluhar G.E. CD200 checkpoint reversal: a novel approach to immunotherapy. Clin Cancer Res. 2020;26:232–241. doi: 10.1158/1078-0432.CCR-19-2234.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-19-2234" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31624103/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=CD200%20checkpoint%20reversal:%20a%20novel%20approach%20to%20immunotherapy&amp;author=Z.%20Xiong&amp;author=E.%20Ampudia%20Mesias&amp;author=G.E.%20Pluhar&amp;volume=26&amp;publication_year=2020&amp;pages=232-241&amp;pmid=31624103&amp;doi=10.1158/1078-0432.CCR-19-2234&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib53">
<span class="label">53.</span><cite>Bohling S.D., Davis E., Thompson K., Kussick S.J., Love J. Flow cytometric analysis of CD200 expression by pulmonary small cell carcinoma. Cytometry B Clin Cytom. 2016;90:493–498. doi: 10.1002/cyto.b.21340.</cite> [<a href="https://doi.org/10.1002/cyto.b.21340" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26584149/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cytometry%20B%20Clin%20Cytom&amp;title=Flow%20cytometric%20analysis%20of%20CD200%20expression%20by%20pulmonary%20small%20cell%20carcinoma&amp;author=S.D.%20Bohling&amp;author=E.%20Davis&amp;author=K.%20Thompson&amp;author=S.J.%20Kussick&amp;author=J.%20Love&amp;volume=90&amp;publication_year=2016&amp;pages=493-498&amp;pmid=26584149&amp;doi=10.1002/cyto.b.21340&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib54">
<span class="label">54.</span><cite>Love J.E., Thompson K., Kilgore M.R. CD200 expression in neuroendocrine neoplasms. Am J Clin Pathol. 2017;148:236–242. doi: 10.1093/ajcp/aqx071.</cite> [<a href="https://doi.org/10.1093/ajcp/aqx071" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5848429/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28821198/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Clin%20Pathol&amp;title=CD200%20expression%20in%20neuroendocrine%20neoplasms&amp;author=J.E.%20Love&amp;author=K.%20Thompson&amp;author=M.R.%20Kilgore&amp;volume=148&amp;publication_year=2017&amp;pages=236-242&amp;pmid=28821198&amp;doi=10.1093/ajcp/aqx071&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib55">
<span class="label">55.</span><cite>McGranahan N., Furness A.J., Rosenthal R. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science. 2016;351:1463–1469. doi: 10.1126/science.aaf1490.</cite> [<a href="https://doi.org/10.1126/science.aaf1490" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4984254/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26940869/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Clonal%20neoantigens%20elicit%20T%20cell%20immunoreactivity%20and%20sensitivity%20to%20immune%20checkpoint%20blockade&amp;author=N.%20McGranahan&amp;author=A.J.%20Furness&amp;author=R.%20Rosenthal&amp;volume=351&amp;publication_year=2016&amp;pages=1463-1469&amp;pmid=26940869&amp;doi=10.1126/science.aaf1490&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><span>Supplemental Methods</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc1.pdf" data-ga-action="click_feat_suppl" class="usa-link">mmc1.pdf</a><sup> (252.9KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p"><span>FALCON Copy Number Variatiaon data</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc10.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc10.xlsx</a><sup> (538.8KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="caption p"><span>Canopy Clonal Fractions</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc11.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc11.xlsx</a><sup> (23.8KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="caption p"><span>Predicted Driver Mutations in Wnt Signaling</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc12.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc12.xlsx</a><sup> (25.9KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material5_reqid_"><div class="caption p"><span>Ordered Mutations, CNVs and Signatures by Phylogeny</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc13.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc13.xlsx</a><sup> (2.7MB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material6_reqid_"><div class="caption p"><span>ctDNA SNVs, indels and CNVs in Patient SCLC 5</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc14.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc14.xlsx</a><sup> (323.2KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material7_reqid_"><div class="caption p"><span>ssGSEA and ImSig SCLC</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc15.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc15.xlsx</a><sup> (98KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material8_reqid_"><div class="caption p"><span>T cell-inflamed GEP SCLC_NSCLC Gene TPM</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc16.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc16.xlsx</a><sup> (336.4KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material9_reqid_"><div class="caption p"><span>T cell-inflamed GEP Scores in SCLC</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc17.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc17.xlsx</a><sup> (190.5KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material10_reqid_"><div class="caption p"><span>Molecular Subtypes SCLC</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc18.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc18.xlsx</a><sup> (128.9KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material11_reqid_"><div class="caption p"><span>Supplementary Figures 1-8</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc2.pptx" data-ga-action="click_feat_suppl" class="usa-link">mmc2.pptx</a><sup> (5.2MB, pptx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material12_reqid_"><div class="caption p"><span>Next Generation Sequencing Summary</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc3.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc3.xlsx</a><sup> (34KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material13_reqid_"><div class="caption p"><span>Patient SCLC 1 Annotated Mutations by Sample</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc4.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc4.xlsx</a><sup> (4.9MB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material14_reqid_"><div class="caption p"><span>Patient SCLC 2 Annotated Mutations by Sample</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc5.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc5.xlsx</a><sup> (1.3MB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material15_reqid_"><div class="caption p"><span>Patient SCLC 3 Annotated Mutations by Sample</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc6.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc6.xlsx</a><sup> (3.8MB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material16_reqid_"><div class="caption p"><span>Patient SCLC 4 Annotated Mutations by Sample</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc7.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc7.xlsx</a><sup> (1.2MB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material17_reqid_"><div class="caption p"><span>Patient SCLC 5 Annotated Mutations by Sample</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc8.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc8.xlsx</a><sup> (2.7MB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material18_reqid_"><div class="caption p"><span>MuSiC Significantly Mutated Genes</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/8474405/bin/mmc9.xlsx" data-ga-action="click_feat_suppl" class="usa-link">mmc9.xlsx</a><sup> (5.4MB, xlsx) </sup>
</div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from JTO Clinical and Research Reports are provided here courtesy of <strong>Elsevier</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1016/j.jtocrr.2021.100164"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/main.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.9 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/8474405/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/8474405/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC8474405%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC8474405/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC8474405/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC8474405/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/34590014/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC8474405/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/34590014/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC8474405/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/8474405/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="OUcXlF4khTvWMv0NHf8M2RxJAblU2HYRq4Ca7xxSyBZgXBvOXewmzZqpH3K75stm">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
